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Bone fracture injuries, as well as their consequences, are important clinical issues. Several 
questions raised about them cannot be answered from observations of patients, therefore 
animal models of human fractures are needed. Zebrafish crush injury was developed here 
as an accurate model for human bone fracture repair. Whilst studies of amputation of the 
zebrafish adult tail attracted much interest as a model for regeneration, there has been 
very limited analysis of the process of repair of bone fractures. To address this, I 
established a zebrafish crush model and characterized it in comparison to mammalian bone 
fracture models. I further evaluated its usage in the zebrafish bone mutant, frf, known 
model for Osteogenesis Imperfecta. I showed striking similarities in the way of fracture 
repair between frf, rodent OI models and humans. I tested common human bone disease 
drugs on the zebrafish crush healing, further showing the usefulness and relevance of the 
model. Upon treatment with Bisphosphonates, human OI drugs, I observed a significant 
reduction in the remodelling stage of fracture healing, as well as in spontaneous fracture 
formation in juvenile OI zebrafish. These results mimic human clinical data. Last, but not 
least, I introduced controlled S. aureus infections to the crush site in order to model human 
S. aureus fracture infections. In conclusion, I established zebrafish crush model relevant to 
human physiology and pathology. I proved its usefulness in bone fracture healing 
characterization studies, in determining bone pathogenicity as well as in bone related drug 
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Regeneration is the process of regrowing lost tissues (Brockes et al., 2001). This 
phenomenon can be found across the whole animal kingdom, however the degree of 
regeneration ability varies between different animal groups. Cnidarians and planarians can 
regrowth each and every part of their body, urodele amphibians are able to restore lost 
parts of organs and limbs including all tissues within them (Fig 0.1), while human 
regeneration capability is highly restricted to only liver, blood and skin (Tanaka and 
Reddien, 2011). The term regeneration is also used to cover processes occurring inside the 
animal body which maintain tissue morphology and function (Carlson, 2005), including 




Figure 0.1 Regeneration involves processes occurring on several biological levels.  
Distinct species might regenerate at none, all, or just a subset of these levels. Functional links 
between regenerative processes at successive levels are likely. It remains unclear which aspects of 
regeneration are homologous across different biological levels. Dotted red lines indicate 
amputation planes, continues red lines indicate wound surfaces; and blue fill indicates 
regenerated body parts (Bely and Nyberg, 2010) 
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Researchers study regeneration in order to fully understand the regenerative processes 
aiming to expand the regeneration potential of humans (Tanaka and Reddien, 2011). 
Urodele amphibians such as salamander and newts have been extensively examined for 
their ability to regrow amputated limbs, precisely restoring their form and cell types 
(McCusker et al., 2015). It has been shown that tissue regeneration is performed by 
sequential dedifferentiation, migration and redifferentiation of residual cells, however this 
process is lineage restricted, meaning that dedifferentiated cells can redifferentiate only 
into the same cell type (fig 0.2) (Tanaka and Reddien, 2011).  
 
Figure 0.2 Lineage-restricted tissue regeneration in transgenetically labelled Axolotl limb  
GFP-labelled Schwann cells regenerated Schwann cells, muscle regenerated muscle, 
cartilage regenerated cartilage but interestingly dermis regenerated dermis, cartilage and 
connective tissues (Tanaka and Reddien, 2011) 
0.0.1. Epimorphic regeneration 
Axolotl restore their limbs through blastema formation in the process called epimorphic 
regeneration (fig 0.3). In this type of regeneration, the lost body part is fully restored, 
without scar formation, from dedifferentiating cells. The whole process can be divided into 
consecutive stages. Firstly, wound epithelium is formed in order to close the wound and 
cover tissues exposed to the external environment. This is followed by formation of an 
apical epithelial cap, formation of which triggers the dedifferentiation of residual stump 
cells, migration towards a forming blastema and proliferation. While the distal tip of the 
blastema proliferates, cells at the proximalblastma start redifferentiating back into cells 
lines they have arisen from, leading to full restoration of tissues and limb internal 




Figure 0.3 Axolotl limb blastema development.  
A) Live images of the time course of limb blastema development showing an intact limb 
(first on the left) and 1, 7, 9, 11, 13, 15, 17, 21, 25, and 31dpa (consecutively to the right). 
B) Schematic representation of the key steps in the regenerative process highlighted during 
blastema development. The tissue components are indicated by the coloured legend. The 
intact limb is composed of multiple tissues including epidermis, connective tissue, muscle, 
cartilage, and nerves, which are organized in a specific way to generate functional 
structures (left). Within hours following an amputation, a wound epithelium covers the 
edge of the severed limb. Within days, this wound epithelium becomes innervated, and 
becomes a specialized signalling centre called the apical epithelial cap. It induces cell 
dedifferentiation in the underlying stump and attracts cells, which accumulate below it. At 
later stages of development, the cells in the basal region of the blastema start to 
differentiate, while the cells at the distal tip of the blastema remain in an undifferentiated 
and proliferative state. Eventually, all the blastema cells differentiate into fully structured 
limb.  (McCusker et al., 2015) 
 
Epimorphic regeneration can also be observed in zebrafish upon tail amputation (fig 0.4) 
(Nechiporuk and Keating, 2002). Blastema formation in zebrafish follows the same steps of 
wound closure, blastema formation and regenerational outgrowth as described previously 
for axolotl, giving rise to the full range of differentiated tissues like blood vessels, muscles, 




Figure 0.4 Adult fin regeneration through blastema formation upon amputation of 
zebrafish tail  
A) Key steps in regeneration following amputation: wound closure, wound closure by 
epidermis and blastemal formation, tail regrowth/ recovery.  
B) Appearance of tissues at key regeneration steps. Dotted lines in B indicate the blastema 
regions.  
(Yoshinari and Kawakami, 2011)  
 
Blastemal formation, growth and differentiation is a highly controlled process. Many 
research groups work towards understanding cellular pathways driving this phenomenon. 
The full signalling network is yet to be determined but over last two decades many 
signalling pathways and cross-talk between them, leading to organised regenerational 
regrowth have been revealed (Fig 0.5) (Wehner and Weidinger, 2015). It is known that FGF 
signalling is needed for blastemal proliferation as it has been shown that in the absence of 
fibroblast growth factors (Fgfs) or their receptors, blastemal outgrowth is arrested (Poss et 
al., 2000, Whitehead et al., 2005). Interestingly, Hh signalling is tightly connected to FGF in 
blastemal outgrowth process. Activation of Hh signalling promotes blastema proliferation 
even in FGF inhibited fins leading to partial rescue of regeneration (Lee et al., 2009). 
Retinoic acid (RA) has also been shown as a crucial regulator of blastemal proliferation 
showing an ability to enhance blastemal growth (Blum and Begemann, 2012). 
Bone morphogenetic protein (BMP) signalling has been shown to play a role in 
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differentiation of osteoblasts and blastemal patterning leading to bony rays formation 
(Stewart et al., 2014). IGF signalling was reported as present during blastemal growth, 
however its inhibition was not powerful enough to supress blastemal proliferation 
suggesting that it plays an indirect role in epimorphic regeneration through cellular 
communication, not in controlling blastemal proliferation (Stewart et al., 2014). 
 
Figure 0.5 Schematic representation of regulation of blastemal proliferation.  
Proliferative and non-proliferative zones are shown. Colours indicate regions where 
pathways are active. Arrows with dotted line indicate predicted interactions (Wehner and 
Weidinger, 2015) 
 
0.1.  Fin ray as a human bone model 
The mechanism of bone restoration through blastemal formation is intriguing. Bone 
regeneration is a unique type of regeneration and up to date only amphibians and teleost 
fish were found to be able to perform it (Tanaka and Reddien, 2011). Researchers hope 
that full understanding of the processes occurring throughout bone regeneration will help 
us to activate those mechanisms in humans. Zebrafish caudal fin is the most commonly 
used model in research studies due to its size and ease of access (Geraudie et al., 1995). 
Moreover, an injured caudal fin does not affect fish mobility, therefore, it does not perturb 
viability. The fin consists of bony rays called lepidotrichia (Fig 0.6 B). Each lepidotrichium is 
made of bone matrix and consist of two hemirays covered with osteoblasts (bone forming 
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cells). Each lepidotrichium is a separate, pipe like structure, filled with fibroblasts and other 
cells types such as pigment cells. Each lepidotrichium has an artery passing through the 
middle of it and two veins laying just along its sides (Fig 0.6 C). Due to their physical 
appearance, bony rays (lepidotrichium) can be used to model diaphysis of the long human 
bone. In both rays and diaphyses, a hard bony structure protects a delicate interior. 
Geometry and transparency of zebrafish tail allow observation of the movement of cells in 
the tail in homeostasis stage as well as during the regeneration process.  
 
Figure 0.6 Adult caudal fin structure 
A) The caudal fin contains of 18 lepidotrichia (bony rays) 
B) Each one is segmented and has ability to bifurcate (split and give rise to two separately 
elongated rays) 
C) Schematic representation of the ray cross section identifying distribution of different 
types of cells 
(Tu and Johnson, 2011) 
0.2. Zebrafish tail bone formation 
Lepidotrichia are formed in the dermis in the process called intramembranous ossification 
(decribed in details below in section 0.6).  Morphogenesis of zebrafish tail skeleton can be 
divided into distinct steps. Starting just after somitogenesis, caudal skeleton forming 
mesenchyme (CSM) arises from the caudal somites (Fig 0.7 A). At the same time, zic1/zc4 
are expressed, blocking further cell proliferation and expression of Twist (Fig 0.7 A). End of 
the body gets dorsally bended at the ural region, while hypurals form ventrally from CSM 
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(Fig 0.7 B). Lepidotrichia are formed as an extension from hypurals following their 
symmetry (Fig 0.7 C). As the fin is growing the symmetrical plane of hypurals and 
lepidotrichia rotates dorsally up to the point where it alines with the midline of the fish 
body axis (Fig 0.7 D). While the tail straightens, it keeps growing in size along with growth 
of fish body. 
 
Figure 0.7 Schematic representation of morphogenesis of zebrafish tail skeleton. 
A) After completion of somitogenesis, caudal skeleton forming mesenchyme (CSM) is 
formed by fusion of caudal somites. Simultaneously, dorsal CSM begun to express zic1/zic4, 
what blocks cell proliferation and twist expression.  
B) Terminal axis bending of the ural region. After terminal axis bending, caudal skeletal 
components form; hypoplasia of epurals is observed in dorsal side and hyperplasia of 
hypurals in ventral side.  
C) Lepidotrichia are formed in a symmetric array with the center of symmetry fixed with 
between hypurals. 
D) Symmetrical plane between hypurals and lepidotrichia rotates as upward bending of the 
urostyle proceeds so that it finally fits in the midline of the body axis. Red lines indicate 
lepidotrichia (fin rays) and green line indicates symmetrical plane (Moriyama and Takeda, 
2013) 
0.3. Zebrafish in research 
Zebrafish was established as a laboratory animal model a few decades ago and has grown 
in popularity (Mariotti et al., 2015). This 3cm teleost fish holds huge research potential 
given its transparency in the embryonal stages, short generation time, and a high fecundity. 
The ability to inject nucleic acid into one cell stage embryos allows a wide range of genome 
modifications leading to gene mutations as well as the creation of transgenic lines (Mariotti 
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et al., 2015). Optical translucence allows for optical screening for fluorescent markers and 
in vivo tracking of cell migration. Moreover, fluorescently labelled cell lines are able to be 
tracked in vivo in larvae as well as in adults without the need for surgical intervention 
(Hammond and Moro, 2012). In just over 20 years, zebrafish research transformed from 
lineage tracing of dye injected cells in developing zebrafish embryos (Schilling and Kimmel, 
1994) and big scale chemical zebrafish mutagenic screens (Driever et al., 1996), to creating 
transgenetically labeled, lineage-specific single cells through the Zebrabow approach (Pan 
et al., 2013) and indels production or single nucleotides exchanges using CRISPR/Cas9 
technique (Irion et al., 2014). Nowadays, researchers employ zebrafish not only for basic 
research to understand fundamental molecular genetic pathways, mechanisms of 
development and organogenesis, but also for disease modelling and regeneration studies, 
including epimorphic regeneration of amputated tails and cardiac regeneration studies.  
0.4. Zebrafish in bone research 
Zebrafish importance in bone research has experienced an exponential growth in the last 2 
decades (Hammond and Moro, 2012, Mackay et al., 2013, Watson and Kwon, 2015, 
Mariotti et al., 2015). Numerous bone mutants were discovered in large-scale genetic 
screens (Driever et al., 1996). Mutants were named based on their phenotypicappearance 
(van Eeden et al., 1996). With help of genetic mapping and genome sequencing, several 
bone related genes were identified as causative of diseases (Howe et al., 2013). Many of 
them were progressively linked to human genetic diseases and now serve researchers as 
zebrafish models of human bone diseases. In addition, they helped to understand disease 
progressions and molecular pathways. Zebrafish models for Osteogenesis Imperfecta (OI) is 
a good example of this process. The first identified OI zebrafish model was the chihuahua 
mutant, and originated from a forward-genetic screen using X-irradiation (Fisher et al., 
2003). Mapping identified a mutation of col1a1a which corresponds to the mutation in the 
human COL1A1 gene, which causes the majority of OI cases (Fisher et al., 2003). Some OI 
patients do not possess mutations in COL1, rather in collagen processing genes (Valadares 
et al., 2014). Identified in another mutagenic screen frilly fins (frf) fish (van Eeden et al., 
1996) displayed an OI phenotype and was identified as an accurate model for human OI 
type XII. frf corresponds to mutations in zebrafish bmp1a gene, which was shown to be 
causative in a number of OI cases (Asharani et al., 2012). This finding helped in define the 
role of Bmp1 in collagen formation in bone (described in greater detail in chapter 2). 
Several other human bone diseases, such as Fibrodysplasia Ossificans Progressiva (Shen et 
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al., 2009), Raine Syndrome (Eames et al., 2011), osteoporosis (Yu et al., 2016, Barrett et al., 
2006) and others were similarly modelled in zebrafish (Mackay et al., 2013). With the 
advantage of CRISPR/Cas9 to induce specific genetic modifications, zebrafish is poised to 
contribute further to modelling human bone diseases. 
0.5. Human skeleton 
0.5.1. Bone types 
The human skeleton is a dynamic and complicated structure. Bones comes in several 
shapes including long bones eg. femur, flat bones eg. sternum, short bones eg. wrist bones 
and irregular bones eg. vertebra (Fig 0.8) (Clarke, 2008).  
 
Figure 0.8 Types of bones in human body 
Examples of different bone types based on bone geometry  
http://classes.midlandstech.edu/carterp/Courses/bio210/chap06/lecture1.html 
0.5.2. Types of bone cells 
In order to understand how bones are formed, we have to be familiar with bone related 
cells types. There are three main types of bone related cells: bone resorbing cells called 
osteoclasts which are derived from hematopoetic stem cells , origin bone forming cells 
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called osteoblasts derived from mesenchymal stem cells and osteocytes which are 
osteoblasts that have become embedded in the bone matrix (Fig 0.9). There are also 
mature quiescent osteoblasts called lining cells, which can be found on bone surfaces (fig 
0.9) (Imai et al., 2013). Balanced activity of these cell types is necessary for bone 
homeostasis and healthy natural bone turn over.  
0.6. Bone forming mechanisms 
Bones are formed through two distinct mechanisms: intramembranous ossification, where 
bone is laid directly into intramesenchymal space by bone forming osteoblasts, or by 
endochondral ossification where bone matrix is deposited over a cartilage scaffold. 
In intramembranous ossification, bone is formed from an ossification centre which forms in 
the fibrous connective tissue membrane from mesenchymal cells clustering together and 
differentiating into osteoblasts (fig 0.10 A1). Newly differentiated osteoblasts secrete 
osteoid (proteinaceous bone matrix), which is slowly mineralised, trapping some 
osteoblasts inside it. Trapped osteoblasts become osteocytes (fig 0.10 A2). Osteoid 
accumulates between embryonic blood vessels and forms random nets of connections. This 
 
Figure 0.9 Human bone cellular structure 
There are three main types of bone related cells: hematopoetic stem cells origin bone 
resorbing cells called osteoclasts, mesenchymal stem cell origin bone forming cells called 
osteoblasts and originated from them osteocytes which are embedded in the bone matrix. 
There are also mature quiescent osteoblasts called lining cells, which can be found on bone 
surfaces (Imai et al., 2013) 
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forms the forming sponge like woven bone on the outside of which, periosteum is formed 
by condensation of vascularized mesenchyme cells (fig 0.10 A3). As the bone grow it 
become more compact, trabeculae thicken and with time, peripheral woven bone is 
replaced with mature lamellar bone, leaving spongy bone in the centre where vascular 
tissue becomes red marrow (fig 0.10 A4). 
In endochondral ossification, bone matrix is laid over the cartilage scaffold. Osteoblasts 
secrete osteoid firstly around the diaphysis (middle part of the bone) of the hyaline 
cartilage model, forming a bone collar (fig 0.10 B1). Concomitantly a primary ossification 
centre is formed in the middle of hyaline cartilage model (fig 0.10 B1) leading to cavities 
formation by calcifying and deteriorating of the centre of the diaphysis (fig 0.10 B2). 
Spongy bone forms around these cavities, which are invaded by the periosteal bud blood 
vessels (fig 0.10 B3). While ossification continues and the diaphysis elongates, osteoclasts 
form a medullary cavity in the centre of the diaphysis by removing residual bone matrix (fig 
0.10 B4). At the same time, secondary ossification centres are formed at both ends in 
remaining cartilage model (fig 0.10 B4). Expansion of all ossification centres lead to 
ossification of the epiphyses and to reduction of initial hyaline cartilage to only epiphyseal 




Figure 0.10 Types of bone formation 
A) Intramembranous ossification  
1 an ossification centre appearance in the fibrous connective tissue membrane  
2 bone matrix secretion within the fibrous membrane  
3 woven bone and periosteum formation  
4 bone collar of compact bone formation and red marrow appearance 
B) Endochondral ossification 
1 bone collar formation 
2 cavitation 
3 spongy bone formation 
4 modularly cavity formation and secondary ossification 





0.7. Comparison between bones of humans and teleost 
fish 
0.7.1. Similarities  
There are many similarities between the bones of human and the bones of fish. 
Understanding them can serve to our advantage in using zebrafish as a model organism for 
human bone disorders (Apschner et al., 2011). Important examples of shared features 
include: the presence of two types of ossification (membranous and endochondral) in 
human as well as in zebrafish (Weigele and Franz-Odendaal, 2016), in both organisms bone 
mineral is composed of hydroxyapatite-like calcium-phosphate crystals (Laize et al., 2014), 
bone matrix deposition is done by alkaline phosphatase positive osteoblasts of 
mesenchymal origin while bone resorption by tartrate-resistance acid phosphatase 
expressing osteoclasts of hematopoietic origin (Witten and Huysseune, 2009).  
0.7.2. Differences  
There are also some differences which are important to remember when examining results 
obtained from zebrafish bone research. Skeletogenicity of zebrafish appears to be more 
complex as compared to the human. Zebrafish bones consist of osteocytic (osteocyte 
containing) bone as well as anosteocytic (osteocyte lacking), while all human bones are 
purely osteocytic (Shahar and Dean, 2013). Mechanosensing in human bones is performed 
by osteocytes, while in zebrafish it is performed by osteoblasts lining the bone. Zebrafish 
bone contains collagen I and II while human bones contain only collagen type I (Laize et al., 
2014). Osteoclasts of zebrafish can be mono- or multinucleated, while human possess only 
multinucleated osteoclasts (Witten and Huysseune, 2009). 
0.8. Genetic markers for bone related cell types 
It is important to mention that genetic markers for the majority of bone formation related 
cell types are shared across the two species. Established markers for different stages of 
cellular maturation of bone cells are expressed. For example, different stages of osteoblast 
maturation can be marked by the range of genetic markers: runx2 for preosteoblast, osterix 
for intermediate osteoblasts and osteocalcin for differentiated osteoblasts (Knopf et al., 
2011). Secreted phosphoprotein 1/Osteopontin (spp1) is another non-collagenous 
extracellular matrix (ECM) protein present in active osteoblasts, which can serve as another 
useful marker (Dedeoglu, 2014). Collagen I (col1) is an important building element of bone 
matrix and its deposition can act as an indicator for osteoblastic activity (Neff et al., 1998). 
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Interestingly, collagen X (col10), which in mammals is used as exclusively cartilage marker, 
in zebrafish has been shown as a bone marker (Fang et al., 2016) as well as cartilage marker 
(Casar-Borota et al., 2016). Sox9 is used as a chondrocyte marker in zebrafish and 
upregulates collagen II (col2) (Yue et al., 2016), the main building element of cartilage. 
Osteoclasts, on another hand, are bone resorbing cells of hematopoietic origin which also 
possess a distinct set of genetic markers. Osteoclast precursors express receptor activator 
of nuclear factor κ-β (rank), while preosteoclasts and mature osteoclasts express cathepsin-
K (CtsK) and tartrate-resistant acid phosphatase (TRAcP) (Sharif et al., 2014). Accurate 
usage and understanding of genetic markers help in revealing molecular events underlying 





1. Chapter 1 – Development of a 
crush injury model in zebrafish 
tail to model human bone fracture  
1.1. Introduction 
1.1.1. Bone fracture 
A bone fracture is a medical condition characterised by loss of bone integrity. It can be 
caused by an accident through mechanical stress on the bone, as well as by genetic 
conditions like Osteogenesis Imperfecta or diseases developed with age like osteoporosis 
(Donaldson et al., 2008). There are several types of fractures, therefore clinicians follow 
complicated classifications to describe particular cases. These include open versus closed 
where skin and muscle penetrance is observed; simple versus comminute, which takes 
under consideration amount of fracture lines and bone fragments created; complete versus 
incomplete where fracture injury spatially separates parts of broken bone or the bone stays 
intact despite the fracture occurrence. In addition, the division can be made based on 
fracture plane (transverse, longitudinal, diagonal, spiral or complex) as well as by broken 
bone dislocation (displacement/shortage, angulation or rotation) (Fig 1.1). Bone fracture is 
a highly complex injury involving the bone and adjacent tissues, therefore detailed 
understating from mechanical, biological and histological aspects is needed (Schneidmuller 
et al., 2011).  
 
Figure 1.1 Types of bone fractures  
A) open versus closed 
B) simple versus comminute 
C) complete versus incomplete 
D) divided based on fracture plane 
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1.1.2. Epidemiology of fracture 
Bone fracture is described as an underestimated medical problem (Donaldson et al., 2008). 
Epidemiological studies showed that annual fracture incident in UK involved 3.6% of the 
population, including patients of all ages (Donaldson et al., 2008). It was rated in the top 
three most common injuries of childhood and adolescence (Baker et al., 2016). The vast 
majority of bone fractures result from complex, multi-tissue injuries and their incidence is 
significantly higher in men than women. The possibility of fracture occurrence is the 
highest in young and middle-aged males and elderly females. Long bone fractures, which 
are the main focus of this study, are the second most common fracture type, just after 
fractures in hands and feet (Donaldson et al., 2008), out of which femoral fractures are the 
most common (Bridgman and Wilson, 2004). However, fractures heal, so do they really 
pose a serious concern to population health? 
1.1.3. Fracture healing research  
According to the literature, there are 5.6 million fracture cases annually happening in USA 
and around 5 to 10% of them do not heal properly (Einhorn, 1995). Predicted causes of 
healing failure include smoking, diabetes, infection and genetics. Previous and current 
smokers were 32% (P = 0.04) and 37% (P = 0.01) respectively less likely to achieve fracture 
union that non-smokers (Castillo et al., 2005), whilst  retrospective case studies indicate 
diabetics have a significantly prolonged fracture healing time (Loder, 1988). Infections are 
known to cause delayed consolidation, failed osteosynthesis and fracture non-union 
(Baruah, 2007). Finally genetic predisposition such as genetic diseases like  Osteogenisis 
Imperfecta (OI) are well documented to lead to non-union fracture formation in 23% of 
Osteogenisis Imperfecta patients (Gamble et al., 1988). Thus, in order to understand why 
those factors lead to healing problems, the process of fracture healing must be fully 
understood (Morshed, 2014). Last few decades showed increased interest in the processes 
of fracture healing. Several case studies (Schilcher et al., 2013) and research articles were 
published which emphasised the need for understanding mechanical, physiological and 
biological aspects of this process in humans.  
1.1.4. Human fracture healing 
The fracture healing process was divided into four healing stages (Fig 1.2) (Bostrom et al., 
1995): inflammation, soft callus formation, hard callus formation and remodelling. Despite 
being well defined by their own characteristics, stages can overlap each other and 
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transitions between them are smooth, no hard defined temporal borders between stages 
can be observed. 
 
Figure 1.2 Models of fracture repair and the cellular participants. 
A) Representative series of images of the four-stage model of fracture healing. Between 
the classical stages 2 and 3, the soft callus is systematically remodeled.  
B) The anabolic/catabolic model of fracture repair that incorporates the concepts of non-
specific anabolism (the early wound repair processes) and non-specific catabolism (soft 
callus remodeling) 
C) Cellular contributors to the fracture repair processes. The source(s) of mesenchymal 
progenitors that are able to differentiate into osteoblasts remain ambiguous. 
(Schindeler et al., 2008) 
 
1.1.4.1. Inflammation (Stage 1) 
Inflammation stage occurs almost immediately after fracture occurrence. Tissue trauma 
leads to activation of wound healing response, inflammatory cells are recruited while 
broken blood vessels create hematoma. Vascularisation and blood supply to the fracture 
site are critical for correct fracture healing, therefore angiogenesis guidance is an important 
role of the inflammation stage. All cellular interactions at this stage are highly regulated at 
the molecular level by cytokines and growth factors, including IL-1, IL-6 and TNFs, PDGFs 
and VEGFs, which possess chemotactic effect on surrounding cells and tissues (fig 1.3) 
(Pape et al., 2010). Inflammatory cells are recruited into crush site and persist there for the 
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first few days to clear foreign bodies, microbes and cellular debris. Phagocytic cells are 
recruited to the injury site to clear it from unwanted particles, created throughout 
homeostasis disturbance.  
 
Figure 1.3 Schematic representation of inflammation stage of fracture healing.  
1) The hematoma formation as a result of blood clotting. The hematoma is characterized by 
low pH and hypoxia, and contains anti-inflammatory and pro-inflammatory cytokines 
together with inflammatory cells from the peripheral blood 
2) Rapid recruitment of immune cells into the site of injury. neutrophils being the first cells, 
followed by macrophages and lymphocytes.  
3) Osteomacs (osteoclasts precursors) are crucial for osteoblast-driven mineralization in 
zones of intramembranous ossification  
4) Inflammatory macrophages mainly contribute to endochondral bone formation  
PMN, polymorphnuclear neutrophils. 
(Claes et al., 2012) 
 
1.1.4.2. Soft callus formation (Stage 2) 
 Soft callus formation is characterised by cartilage deposition around the fracture site. A 
ball of cartilage is formed by resident chondrocytes or recruited mesenchymal stem cells to 
encapsulate the breakage, stabilizing it and holding broken bone ends in place (fig 1.4. 2). 
This stage is crucial in mechanically unstable fractures. In case of stable fracture 
occurrence, where broken bone parts stay intact and no deviation from the original 
location is observed, stage 2 is sometimes omitted and intramembranous bone formation 
can be observed. Cartilage callus formation stage is characterised by chondrocyte 
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recruitment to the fracture site, collagen type II deposition and expression of growth 
factors such as TGF –β2 and –β3, PDGF , IGF and FGF-1 (Bianco and Robey, 2000, Bhakta et 
al., 2006). 
1.1.4.1.  Hard callus formation (Stage 3) 
Hard callus formation is performed by osteoblasts, which can either already reside near the 
fracture site or arise from osteoprogenitors activated by osteogenic factors. During this 
stage, the soft callus is vascularised and gradually replaced by hard callus through the 
mineralized material deposition, which is laid onto cartilage scaffold leading to the woven 
bone formation (fig 1.4. 3). Cartilage scaffold usage in mineralization support indicates 
endochondral ossification. Intramembranous ossification occurs when cartilage formation 
is omitted and mineralized tissue is laid directly onto fractured bone (Bielby et al., 2007). 
Hard callus ensures rigidity, eliminates the movement and reduce flexibility at the fracture 
site. 
1.1.4.2. Remodelling (Stage 4) 
Remodelling is characterised by replacing of woven bone by cortical and trabecular bone 
and trimming bony callus away (fig 1.4. 4). Progressive reduction in the callus width is a 
result of osteoclasts work and is used as an indicator for correctly progressing remodelling 
stage. In humans, it can last up to a few years to observe full callus remodelling. However, 
the fracture site might be recognised even years later. 
 
Figure 1.4 Four stages of human bone fracture healing 
1) inflamation and hematoma formation  
2) Fibrocartilsginous callus formation  
3) Bony callus formation  





Since the four stages recovery model had been first established, the vast amount of 
research has been done to reveal molecular pathways underlying fracture healing process 
(Slowik and Bermingham-McDonogh, 2013). Each of stages is related to the specific cell 
types, driven by certain molecules e.g. cytokines and growth factors (Bolander, 1992). 
However, only partial understanding can be obtained from human fractures as they do not 
permit experimental intervention. In order to elucidate the process of fracture healing, 
animal models have been employed (Hammond and Moro, 2012). 
1.1.5. Animal fracture models  
Several species were used as models to mimic human bone fracture conditions. This 
includes big mammals such as sheep, whose bone size and structure was shown to be very 
similar to human and used for mechanobiological studies of fractures (Egermann et al., 
2008). Unfortunately, studies using sheep are very costly due to size and lifespan of those 
animals, which lead to limited repeat numbers of experiments. Similar limitations were 
reported in research on pigs and goats which have been widely used to model fracture 
infection (Reizner et al., 2014). Other big animals used for bone fracture studies were dogs 
(Lenehan et al., 1985), which have been used for decades for testing mechanical and 
radiological fracture treatments. However, due to ethical issues and several public protests 
experiments performed on dogs were limited in recent years.  
With recent developments in genome manipulation and transgenesis, the last two decades 
brought a deeper understanding of cellular movements through cell lineage tracing 
techniques. This has contributed to a shift towards small animal usage for bone research. 
The tissue-specific cellular contribution is easier to test on small rodents like rats, rabbits or 
genetically modified mice. These were widely used for bone fracture modelling (Reizner et 
al., 2014, Garcia et al., 2013). However, bone examination in small rodents can be 
performed only by surgical intervention by opening the flesh in order to reach to the bone. 
There was a real need for a model organism in which bone could be examined 
noninvasively. It has been previously shown than certain bones of teleost fish can be 
examined noninvasively (Hammond and Moro, 2012), therefore progression of bone 
healing could be tracked in those. Following this trend, teleost fish were recently used in 
bone fracture research (Sousa et al., 2012, Geurtzen et al., 2014, Takeyama et al., 2014). 
This was first explored by Sousa et al. (2012) and compared fracture repair to  epimorphic 
regeneration of zebrafish tail after amputation (Sousa et al., 2012). The ray fracture model 
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was expanded by Geurtzen et al. (2014), comparing ray fractures to skull injuries, and 
demonstrated osteoblast dedifferentiation, migration, and re-differentiation at both injury 
types. Osteoblast and osteoclast recruitment to the crush site was also assessed in medaka, 
another small teleost fish, presenting recruitment of osteoblasts and two types of 
osteoclasts to the fracture site (Takeyama et al., 2014).  
1.1.6. A new zebrafish bone crush injury model 
Sousa et al. (2012) proposed that partial amputation of zebrafish tail was not an ideal 
approach to model human bone fractures. They decided to compare zebrafish responses to 
the amputation and to the ray fracture. Firstly, they examined both regenerative processes 
side by side through amputating one lobe of the tail and crushing  rays in the other lobe (fig 
1.5 A). They reported strong changes in tissue architecture at the crush side comparing to 
hardly distinguishable amputation plane at 10dpc/a (fig 1.5 B, C). They showed that crush 
injury destroys only bone elements and epidermis (fig 1.5 D) and reported uncalcified callus 
formation around the crush site and suggested similarities to human bone fracture healing 
(fig 1.5 E, F). 
 
Figure 1.5 Differences in tissue architecture after crush and amputation induced 
regeneration in the same caudal fin.  
A–C) Bright filed image of a caudal fin after crush and cut at (A) 24hpc/a and (B) 10dpc/a. 
(C) Magnification of the inset in picture B.  
D) Alizarin Red staining for bone matrix at 48 hpc; dashed lines indicates the region of 
callus formation that is not stained with Alizarin Red.  
E) Bright field confocal image of 48hpc injury site, the arrow highlights the callus structure. 
F) Hematoxilin/Eosin staining in a transversal section of a 48hpc ray.  
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Arrowheads indicate the amputation plane and asterisks indicate crush injury area in A and 
B, and crush injury sites in C and D. Scale bar corresponds to 500 µm in A and B, 200 µm in 
C, 100 µm in D and 50 µm in E and F (Sousa et al., 2012) 
 
Sousa et al. (2012) proceeded to conduct comparative molecular characterisation. Firstly 
blastema formation was assessed using the blastema marker muscle segment homeobox B 
(msxb) (Nechiporuk and Keating, 2002). They reported that blastema formation was 
delayed in the crush injury as compared to amputation (fig 1.6 A-D). In addition, they 
examined proliferation around the injury side using the proliferation marker PCNA (fig 1.6 
E, F) and concluded that initiation of proliferation was also delayed after crush injury, when 
compared with epimorphic regeneration after amputation. 
 
Figure 1.6 Blastema marker, msxb, and proliferation after crush injury.  
A–D) Whole mount in situ hybridization for msxb mRNA at (A) 24hpc (B) 24hpa (C) 48hpc 
(D) 48hpa.  
E-F) Immunohistochemistry for the proliferation marker PCNA (green) at (E) 48hpc around 
the crush injury site and (F) 48hpa blastema (distal region is to the left and proximal to the 
right). DAPI (blue) is staining the nuclei.  
Arrowheads indicate the amputation plane and asterisks indicate crush injury sites. Scale 





They went on to molecular examination of bone formation. They decided to use early 
skeletogenesis marker osterix (osx), a marker of the intermediate stages of skeletogenesis 
collagen 1 (colI), and also a late differentiation marker involved in mineralisation, 
osteonectin (osn) (Sousa et al., 2012). Based on results of the In Situ Hybridization they 
concluded delayed skeletogenic gene expression in crush as compared to amputation (fig 
1.7) (Sousa et al., 2012). 
 
Figure 1.7 Expression of skeletogenesis genes after crush injury.  
A–L) Whole mount in situ hybridization for mRNA detection  
A–D) osterix at (A) 24hpa; (B) 24hpc (C) 48hpa (D) 48hpc 
E–H) collagen I at (E) 24hpa (F) 24dpc (G) 48hpa (H) 48hpc  
I–L) osteonectin at (I) 24hpa (J) 24hpc (K) 48hpa (L) 48hpc  
Arrowheads indicate the amputation plane and asterisks indicate crush injury sites. Scale 
bar corresponds to 100 µm in all panels. (Sousa et al., 2012) 
 
In order to assess whether the delayed osteogenic gene expression delayed the deposition 
of the new bone tissue, they used Anti-Zns5 antibody which labels osteoblast at any stage 
of their differentiation. The results reassure researchers that osteogenesis is delayed based 
on the lack of Anti-Zns5 antibody expression in the crush site at 24hpc in contrast to 24dpa 




Figure 1.8 Skeletal cell deposition was delayed and patterning was affected after crush 
injury.  
A–F) Immunohistochemistry with the antibody anti-Zns5 to detect skeletal cells. (A) 24hpc, 
the arrow highlights the lack of bone cells deposition (B) 24hpa (C) 48dpc (D) 48hpa (E) 
6dpc (F) 6dpa, near the amputation plane.  
Arrowheads indicate the amputation plane and asterisks indicate crush injury sites. Scale 
bar corresponds to 50 µm in all panels. (Sousa et al., 2012) 
 
Interestingly, experiment using Anti-Zns5 antibody also showed structures of newly formed 
bone and differences in the new bone geometry between crush and amputation injuries 
(fig 1.8 C-F). Bone formed around the crush had a spherical shape and seem to be 
deposited from proximal as well as distal sides of the injury, in contrast to amputation 
where bone is structured in more organised way, formed in the straight proximal to distal 
line. Differences in new bone patterning led authors to conclude that crush injury leads to 
prolonged bone repair as compared to amputation (Sousa et al., 2012). 
Overall, Sousa et al. (2012) concluded that regeneration after crush injury is delayed when 
compared with amputation, however both of them share similar molecular mechanisms. 
Authors suggested that crush injury leads to prolonged bone repair as compared to 
amputation and that it may impair bone re-patterning (Sousa et al., 2012). 
1.1.7. Aim of experiments shown in this chapter 
Inspired by those findings I have decided to look more closely into similarities and 
differences between crushing and amputating bones in zebrafish tail as well as trying to 




1.2. Materials and methods 
1.2.1. Animal licence 
All experiments performed in UK were approved by Ethical Review Committee under 
Project Licence no 40/3459 and Principal Personal Licence no 40/10722. Experiments 
performed in Singapore were under The Institutional Animal Care and Use 
Committee (IACUC) number 140924. 
1.2.2. Zebrafish husbandry 
Zebrafish lines used for experiments performed in UK were bred and housed in the Bateson 
Centre aquaria in The University of Sheffield, under strictly regulated conditions controlled 
by UK Home Office. Fish used for experiments in Singapore were bred and housed in the 
aquaria of Institute of Molecular and Cell Biology in Biopolis, Singapore and were controlled 
by the Agency for Science, Technology and Research and The Institutional Animal Care and 
Use Committee. All were kept in a regulated 14:10 hour light-dark cycle. 
1.2.3. Zebrafish nucleic acid collection 
1.2.3.1. Extraction of zebrafish genomic DNA 
Whole zebrafish embryos, the tip of adult zebrafish tail or scales were used as a source for 
genomic DNA. Adult tissue was collected from live, anesthetised individuals. Zebrafish were 
fin clipped or scaled by gentle body stroking with forceps along the body axis from anterior 
to posterior. Collected tissues were digested for 4h in 55˚C in lysis buffer with 1% 
Proteinase K (Boehringer 1000144, 10mg/ml in PBST stock). The enzymatic reaction was 
stopped by 15min enzyme inactivation at 98˚C. Ready to use genomic DNA was stored at -
20˚C until required. 
1.2.3.2. Embryos RNA Extraction 
Pools of embryos of the same developmental stage were homogenized in 200µl of Trizol 
(Sigma-Aldrich, T9424), another 300µl of Trizol was added, mixed and incubated at room 
temperature (RT) for 5min. 100µl of chloroform was added, the mixture was shaken for 
15sec and incubated for 3min at RT. Each tube was centrifuged at 12000G for 10min at 4˚C. 
The supernatant was removed, the pellet was washed with cold 70% ethanol and spun at 
7500G for 5min. Ethanol was removed and the pellet was left to air-dry, then dissolved in 
30µl water. Concentration was checked on nano-drop spectrophotometer, and size was 




1.2.3.3. cDNA Synthesis 
Pre-reaction mix was prepared from 1µl Oligo(dT) Primer (Invitrogen, 18418012), 11µl of 
1µg of extracted RNA dissolved in water and 1µl of 10mM dNTP Mix. Components were 
mixed together, incubated for 5min at 65˚C and cooled down on ice for 2min. Remaining 
reaction components were added: 4µl of 5x First-strand buffer, 1µl of 0.1M DTT, 1µl of 
RNAse inhibitor and 1µl of Superscript III RT. All 20µl were mixed and incubated for 1 hour 
(1h) in 50˚C for cDNA synthesis followed by 15min in 70˚C for polymerase inactivation. The 
reaction’s products were stored at -20˚C until needed. 
1.2.4. In situ Hybridization  
1.2.4.1. Probe design 
Sequences used for probe design were downloaded from Ensembl database 
(www.ensembl.org). Primer sequences were designed using the online primer designing 
website, Primer3 (www.Primer3.com). Probe length was kept between 600 and 1100bp 
ensuring 3’UTR incorporation. Primers used for probe templates preparation are listed in 
Table 1.2. 
Name of the 
primer 
Sequence of the primer in 5’ to 3’ direction 
5’ -> 3’ 
bglap f    ACAGAAGCGAACATGAAGAGTC 
bglap r T3 GGATCCATTAACCCTCACTAAAGGGAACCCATAGTAGGTTTTATAGGCGG 
Sox9a f GCACAAGAAAGATCACCCCG 
Sox9a r T3 GGATCCATTAACCCTCACTAAAGGGACGACTCATATGGGCATGCA 
sox9b f CCGTACCCCACATTCAGCTA 
sox9b r T3 GGATCCATTAACCCTCACTAAAGGGACCCTTCCCTCATAGCAGG 
col2a1a f AGAAGACATCCAGACTGCCC 
col2a1a r T3 GGATCCATTAACCCTCACTAAAGGGGGAGTGGGATGGATTGGGAA 
col2a1b f AACAGAAGTGCTTCCGAACG 
col2a1b r T3 GGATCCATTAACCCTCACTAAAGGTTGTCCTGATTCGAGGCTCT 
Fbl1f CAGCCTTCAAAGGGTGATGC 
Fbl1r T3 GGATCCATTAACCCTCACTAAAGGTGTGTCCACCAGTGGGCAGCGCA 
hmcn2 f CAGCCCTCAGCTCACATACA 
hmcn2 r T3 GGATCCATTAACCCTCACTAAAGGCACTGGAGGAACCAACACCT 
il1f ATGGCATGCGGGCAATATGA 
il1r T3 GGATCCATTAACCCTCACTAAAGGCTAGATGCGCACTTTATCCT 
ctsK f CCTTAGTCCTCAGAACCTGGTG  
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ctsKr T3 GGATCCATTAACCCTCACTAAAGGATCCAGTACTTCTTGCCTCTCG  
Col10f CCCATGCTTGTTTTCCTGTT 
Col10r T3 GGATCCATTAACCCTCACTAAAGGTCCAAACAGATCTGACCTTGC 
spp1 f GGACCAGGCAGCTACAGAAG 
spp1r T3 GGATCCATTAACCCTCACTAAAGGCACTGCCGTCTGTCGTCTAA 
Col1 f GCCAGCAGATTGAGAGCATC 
Col1 r T3 GGATCCATTAACCCTCACTAAAGGTGAGCAAAAGCGACGAACAA 
Table 1.2 List of primers used for probes templates preparations. Sequence in bold 
indicate T3 polymerase binding site. 
1.2.4.2. Template preparation 
RNA probes were synthetized from genomic DNA, cDNA or premade plasmids. PCR reaction 
used appropriate primers. 100µl PCR reaction consisted of 20ng of plasmid (or 1µl of 1:10 
dilution of cDNA or genomic DNA) and 1µl of each primer (from 25µM stock). Primers were 
designed with T3 sequence attached to 5’ end of the reverse primer to allow RNA synthesis 
directs from PCR product (highlighted in red, Table 1.2). Each PCR reaction consisted of 
initial denaturation 3min step at 95˚C followed by 35 cycles consisting of 45sec 
denaturation at 95˚C, 30sec annealing at the annealing temperature ranging from 50 to 
61˚C and elongation at 72˚C, with timing depending on the length of expected PCR product. 
After 35 cycles, the reaction was incubated for additional 10min at 72˚C. As the final step, 
the reaction was cooled down to 4˚C and product was run on a 1% agarose gel to clean it 
up and to check product size by comparison to 2-Log DNA Ladder (New England BioLabs 
N3200L) run along the side. Upon correct result DNA band was gel extracted using QIAquick 
Gel Extraction Kit (QIAGEN ID28706) following kit protocol and kept at -20˚C until required 
as the template for RNA probe synthesis.  
1.2.4.3. RNA probe synthesis 
Probe RNA was transcribed from DNA templates. Transcription mix was prepared including 
1µg DNA dissolved in nuclease free water to a volume of 13µl, 2µl of DIG RNA Labelling mix 
(Roche 11277073910), 1µl of Protector RNase Inhibitor (Roche 03335399001), 2µl of 10x 
Transcription buffer and 2µl of T3 RNA polymerase (both from Roche 11031163001), mixed 
well and incubated for 2h at 37˚C. 1µl of TURBO™ DNase (ThermoFisher AM1348) was 
added and incubated for 15min at 37˚C. 30µl of nuclease free water and 30µl of Lithium 
chloride were added (ThermoFisher AM1348), mixed thoroughly and placed for 30min at -
20˚C. Tubes were centrifuged at 4˚C and 12000G for 15min to precipitate the RNA. The 
supernatant was removed, the pellet was washed with 1ml of 70% ethanol, centrifuged 
again and after removing all alcohol, re-suspended in nuclease free water.  
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1.2.4.4. In situ hybridization reaction 
In situ hybridization of selected genes were performed using the standardized protocol for 
whole mount samples adapted from Thisse and Thisse (2008) . Probes were designed and 
synthesized as described above. Fish tails collected after amputation and after crushes 
were arranged based on time of recovery after injury. Amputated tails of the same 
recovery times as crushed tails were pooled in one Eppendorf tube, e.g., 3 days post crush 
(3dpc) with 3 days post amputation (3dpa). 1.5ml tubes were used throughout the 
experiment. Tails were washed gradually with 100% methanol for and moved to -20˚C for 
storage. 
Solutions used (50ml):  
HYB- 25ml formamide 
12.5ml 20X SSC  
250µl 20% Tween-20  
460µl 1M Citric acid 
fill with H2O up to 50ml 
HYB+ 25mg tRNA  
50µl heparin stock  
Topped up to 50ml with HYB- 
Blocking Buffer 1ml sheep serum  
100mg BSA 
Topped up to 50ml with PBST  
Staining buffer 
 
5ml tris pH9.5 1M 
2.5ml MgCl2 1M 
1.66ml NaCl 4M 
250µl 20% Tween-20 
Topped up to 50ml with PBST 
Bleaching solution 10% H2O2 
0.5 XSSC 
5% Formamide 
Table 1.3 List of solutions used for ISH  
 
On day 1, tails stored in 100% methanol at -20˚C were rehydrated through 
methanol series 10min in 60% Methanol in PBST, 10 min in 30% Methanol in PBST, 
then washed in PBST 2 x 5min. Tissues were digested 10 min with Proteinase K (10 
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µg/ml) in PBST and re-fixed in 4% PFA-PBS for 20min in room temperature (RT). 
After four sets of 5min PBST washes samples were placed in HYB+ (Table 1.3) in 
70˚C for 2h then HYB+ was replaced by HYB+ containing 1 in 200 dilutions of 
antisense RNA probe and hybridized at 70˚C, overnight. 
 
Day 2 consisted of series of 10min washes in 70oC: 25% 2X SSCT/75% Hyb- (Table 
1.3), 50% 2X SSCT/50% Hyb-, 75% 2X SSCT/25% Hyb-, 2X SSCT. Then 30min 0.2X 
SSCT wash in 70oC. Followed by series of 10min washes in Room Temperature (RT): 
25% PBST/75% 0.2X SSCT, 50% PBST/50% 0.2X SSCT, 75% PBST/25% 0.2X SSCT and 
PBST. After washes samples were placed in blocking buffer (Table 1.3) for 3-4h at 
RT and incubate in antibody solution overnight with agitation (anti-DIG 1:10000) at 
+4°C. 
 
Day 3 consisted of six sets of 15min washes in PBST and two sets of 5min washes in 
freshly prepared staining buffer (Table 1.3). Afterward, samples were moved to 
staining solution prepared with staining buffer, 4.5µl of 50mg/ml NBT and 3.5ul 50 
mg/ml BCIP per each 1 ml of solution. Reaction run at RT until staining 
development then it was stopped by 15min wash in PBST 1mM EDTA. Samples 
were re-fixed in 4% PFA 30’ and put through MeOH series. They were kept in 100% 
methanol for 2h and gradually rehydrated (60%, 30% MeOH in PBST). After two 
sets of 5min washes in PBST, specimens were bleached in bleaching solution (Table 
1.3) for 10min in 37 °C, wash three times in PBST and put through glycerol series 
(50%, 100%). They were kept in RT in 100% glycerol until imaging.   
1.2.5. Imaging 
Stained samples were imaged on Axio Imager Z2 (Zeiss). 
1.2.6. DNA constructs/plasmids synthesis for transgenic 
line creation 
1.2.6.1. Multi Gateway  
Multi Gateway cloning system (Invitrogen) was used to create transgene contains plasmids. 
Multi Gateway system allows for simultaneous cloning of 3 DNA fragments: p5e landing on 
5’end of the construct, pMe in the middle and p3e on the 3’ end, into a backbone called 




Figure 1.9 Graphical representation of Gateway reaction 
Gateway enzymatic reaction allows for simultaneous insertion of 3 entry vectors into 
destination vector in pre-determined order. Content of p5e entry vector will always be 
instrted at 5’ end, pMe in the middle and p3e at 3’ end. Backbone of destination vectoe can 
be modified for specific use e.g. to carry tol2 sides allowing further construct incorporation 
into zebrafish genome. 
 
For zebrafish research, the destination vector was previously modified to carry Tol2 sites as 
well as marker gene CryA-Venus. Tol2 sites allow incorporation of the construct into 
zebrafish genome after microinjecting it into one cell stage zebrafish embryo together with 
Tol2 transposase mRNA. CryA promoter drives Venus expression in the lens as a reporter 
gene. Upon successful insertion of the construct into the fish genome, Venus fluorescence 
protein was expressed in CryA expressing cells – in the eyes. This allowed fast screening of 
embryos for construct incorporation. In my constructs, p5e was carrying promoters of 
interest, either osteocalcin (bglap), osterix or twist, which were supplied from HR lab 
resources. pMe carried Kaede coding gene, a photosensitive protein whose conformation 
can be changed by exposure to UV light (Li et al., 2010), resulting in a shift of absorbance 
and emission of the light spectrum, visually changing fluorescent protein from green to red. 
Such a photosensitive protein permits lineage tracing of specific cell types. P3e contained 




1.2.6.2. Cloning promoters into p5e  
Promoters were cut from preexisting plasmids, appropriate restriction enzymes were 
chosen, compatible with existing p5e, in order to create desired p5e plasmid. Osx was cut 
out from osterix:mCherry plasmid from lab resources by BamHI and KpnI enzymes and 
ligated into previously digested with the same unicutters p5e MSCII plasmid, creating 




Figure 1.10 graphical representation of restriction digest cloning  
This example shows cloning of osx promoter into p5e entry vector, which can be further 
used in Gateway cloning reaction in order to create constructs driving other genes under 
control of osx promoter.   
1.2.6.3. Restriction digests cloning 
Components of restriction digest (Table 1.4) were mixed well and incubated at 37˚C for 2h 
allowing full digestion of DNA. Digested plasmids were run on 1% agarose gel along with 
3µl of loading buffer allowing DNA visualization. DNA band sizes were checked under the 
UV light. Bands of expected sizes were excised and extracted using QIAquick Gel Extraction 
Kit (QIAGEN Cat No/ID28706) following kit protocol. Gel extracted DNA was used for 
ligation reaction (Table 1.4) run for 10min at 25˚C, followed by transformation. 
 
 
Restriction digest (20 µl) 0.5µl of each enzyme 
2µl of adequate to this enzymes buffer 
2µg of plasmid DNA 
water topped up to 20µl 
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1% agarose gel 0.6g agarose 
60ml TBA (electrophoresis buffer) 
2µl ethidium bromide 
Ligation reaction 8µl of gel extracted DNA 
1µl of Quick Ligation Reaction Buffer 
1µl of Quick T4 DNA Ligase 
Table 1.4 Reagents needed for Restriction digest cloning 
1.2.6.4. Transformation 
TOP10 competent cells (ThermoFisher C404006) were used for transformation. 5µl of 
ligation reaction were added to 45µl of thawed on ice cells. 30s heat shock at 55˚C was 
performed to force plasmid uptake by hollowed bacteria. Recovery phase of 1h at 37˚C in 
SOC medium was followed by overnight incubation on LB agar with appropriate antibiotic 
selection. 
1.2.6.5. Plasmid DNA isolation 
Ten colonies were picked from each LB plate using sterile pipette tips and transferred to 
2ml of LB with appropriate antibiotic for 16-18h incubation on 37˚C shaker. Next day 
bacteria were harvested by centrifugation and plasmid was extracted with QIAprep Spin 
Miniprep Kit (QIAGEN Cat No/ID: 27106), used following manufacturer protocol. 
1.2.6.6. Cloning confirmation 
Isolated plasmid was subjected to restriction digest with a dual cutter digesting plasmid 
into two uneven parts which allow determination of successful cloning.  
1.2.6.7. Gateway Cloning - LR reaction 
Accurate amounts of reaction components (Gateway® LR Clonase® II Enzyme mix, 
Invitrogen, Catalog number: 11791100) were added to ensure high cloning efficiency. The 
protocol was adapted from original stated in manual provided by LR clonase manufacturer, 
Invitrogen. 10 µl reaction consisted of 10fmol of each entry vector, 20fmol of destination 
vector, 1µl of TE buffer and 1µl of LR clonase. The Reaction was mixed well and incubated 
for 16h at 25˚C, followed by reaction termination by addition of 1µl ProK provided in the kit 
and 10min incubation at 37˚C, then stored at -20˚C until transformation.  
1.2.7. Microinjections into zebrafish embryo 
Pairs of adult zebrafish were kept overnight separated from each other by the transparent 
divider. Just before the start of injections, the divider was removed. After 5min eggs were 
collected and kept in embryo water with 0.1% of methylene blue ready for injections. Glass 
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needles used for injections were pulled with Sutter Instruments P-97 Flaming/Brown 
Micropipette Puller using Standard Wall Borosilicate Tubing without Filament (Sutter 
Instruments B100-50-10). Narishige IM-300 Microinjector was used. The nucleic acid in the 
concentration of 20ng/µl was injected into 1cell stage eggs lined up against microscope 
slide placed in the petri dish. For plasmid DNA injections 40ng/µl of plasmid was mixed 1:1 
with Tol2 RNA prior to injections.  
Despite successful transgene incorporation and transgenic lines creation, lines were not 
used in experiments presented in this thesis due to weak fluorescence signal. 
1.2.8. Zebrafish transgenic lines  
The followed transgenic lines were used: myeloid-specific peroxidase (mpx) transgenic line 
Tg(mpx:GFP), previously known as Tg(mpo:GFP) (Renshaw et al., 2006) marking neutrophils 
- used for assessing inflammation in injured zebrafish; osterix (osx) transgenic line 
Tg(osx:mCherry) (Spoorendonk et al., 2008) marking osteoblasts - used for ossification 
tracing; and ETS transcription factor a (fli1) transgenic line Tg(fli1:EGFP) marking blood 
vessels (Lawson and Weinstein, 2002) - used in assessing changes in blood vessel sizes over 
time. 
All of the above-mentioned transgenic lines were used to analyse temporal progression of 
crush healing and stages of recovery.  
1.2.9. Tail amputation and crush injury 
Adult zebrafish, 1 year old (1ypf – year post fertilization) +/- 2 months, were anaesthetized 
in 0.013% tricaine in fish water and placed on a petri dish. Excess water was removed by 
paper tissue and the fish was positioned on its side, anterior to the left, dorsal to the top. 
The tail was spread out evenly on the surface of the petri dish. Dish with anesthetized fish 
was placed under the dissecting stereomicroscope. A scalpel blade was used to amputate 
end of the tail at the position of most proximal ray bifurcation. Alternatively, forceps 
number 5 were used to perform a bone crush. Four crushes per tail were introduced, on 
the 2nd and 4th ray from both dorsal and ventral sides of the tail at the second segment 
anterior to the first level of bifurcation (Fig 1.11 A). Bone crush was performed in the 
middle of the segment with the minimal strength needed to crush through both of the 
hemirays without impacting for adjacent tissues (Fig 1.11 B). After surgery, fish were 




Figure 1.11 Crush injury location on the zebrafish tail 
A schematic representation of zebrafish tail with amputation plane indicated by dashed 
line and crush sites indicated by crosses 
B schematic representation of one bony ray with a crush site indicated by the cross 
Image adapted from Rolland-Lagan et al. (2012) 
 
1.2.10. Tail collection and storage 
Subsequent tail collection was planned based on the required stage of regeneration/repair. 
Anesthetized fish were culled through instant brain disruption by needle poke, following 
Schedule1 rules and regulations for animal husbandry and humane culling. Fish was 
instantly moved to petri dish and a scalpel blade was used to dissect the tail off. Collected 
tails were placed in 4% Paraformaldehyde (PFA) solution and kept at 4˚C, shaking, 
overnight (o/n). The following day, specimens were washed in PBST briefly, then moved 
through methanol series consisting of 30%, 60%, and 100% methanol. Specimens were kept 
10 min in each solution and then stored in 100% methanol at -20˚C. 
1.2.11. Cartilage and bone staining – fixed tissues 
Alizarin red and alcian blue are well-known dyes used for skeletal staining. Many protocols 
were established to ensure the best possible performance. I adjusted these standard 
protocols to produce best results in available conditions. 
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1.2.11.1. Two colour cartilage and bone staining  
Specimens stored in 100% methanol in -20˚C were moved to Alcian blue solution 
(consisting of 0.1% Alcian Blue (Sigma-Aldrich, A5268), 20% 0.1M Acetic Acid (Fluka, 38050) 
and 80% methanol) for overnight staining at room temperature. This was followed by a 
methanol/PBS wash series consisting of 10min washes in 100%, 60%, 30% methanol, and 
two 10min PBST washes. Subsequently, samples were pre-incubated in 0.5% KOH for 15min 
and moved to 0.2% Alizarin Red solution in 0.5% KOH for overnight staining at room 
temperature. Next day, three sets of 5min washes with 0.5% KOH were performed 
followed by 1h hydrogen peroxide bleaching (3% H202 in 1% KOH). Upon completion, three 
sets of 10min PBST washed were performed and samples were moved to glycerol for 
storage (UltraPure™ Glycerol, Invitrogen, Catalog number: 15514011). 
1.2.11.2. Separate colour staining 
When separate staining of cartilage and bone was required, the above protocol was divided 
for two separate staining protocols, either for Alizarin Red or Alcian Blue, to give better 
staining resolution.  
1.2.11.3. HCl Alcian Blue staining 
Rehydrated tissues kept in 100% methanol at -20˚C were rehydrated through methanol 
series (100%, 60%, 30%) and washed twice with PBST for 10min then moved to Alcian Blue 
stain solution (1% HCl, 0.1% Alcian Blue in H2O) for overnight staining. Next day, the 
samples were washed 15min in PBST and bleached in the bleach solution (0.3% H202, 1% 
KOH in water) for 30min at 37˚C, then washed in PBST and stored in glycerol.  
1.2.11.4. A two-colour acid-free cartilage and bone stain 
Stored tissues were re-hydrated from methanol as above and moved to acid-free double 
stain solution contain 1ml of Part A solution and 10µl of Part B solution. Part A consist of 
0.02% Alcian Blue, 0-200mM MgCl2 and 70% ethanol while Part B is a 0.5% Alizarin Red in 
water. After staining, tissues were bleached in 1.5% H202 and 1% KOH for 20min in room 
temperature, then moved to 20% glycerol with 0.25% KOH for 30min, 50% glycerol with 
0.25% KOH for 2h and finally to 50% glycerol with 0.1% KOH for storage, kept in 4˚C until 
imaging.  
Protocol was adapted from Walker and Kimmel (2007)  
1.2.12. Fluorescent bone staining in vivo 
Alizarin Red S (Sigma-Aldrich, A5533) and Calcein (Sigma-Aldrich, 17783) were used for 
fluorescent in vivo bone staining. 0.001% Alizarin Red or 0.0005% calcein in fish tank water 
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was used for overnight staining. Fish were immersed in small tanks in 200ml of staining 
solution the night before imaging. Following day, they were moved to clean water for a 
quick wash, anesthetized and imaged under a Zeiss fluorescent microscope.  
1.2.13. Callus size measurements  
Callus sizes were measured in AxioVision software. The width of the callus was measured in 
µm and normalized against the width of an unbroken part of proximal, segment, in order to 
omit ray size differences between individuals and obtain actual callus sizes. Therefore, data 





1.3.1. Fracture healing is considered a distinct type of 
regeneration  
Fracture healing leads to restoration of the original bone from prior to the injury, without 
fibrous scar formation (Marsell and Einhorn, 2011). Fracture healing can be considered as a 
distinct type of regeneration, as it leads to restoration of lost tissue in almost exact form 
(Epari et al., 2010). In zebrafish, regeneration usually refers to their ability to regrow lost 
tail through the blastema formation and epimorphic regeneration. Therefore, the starting 
point for this project was to compare a crush in zebrafish caudal fin to the process of 
amputated tail regeneration, widely explained in the literature (Akimenko et al., 1995, Ng 
et al., 2014). 
1.3.2. Experimental setup  
For 7 consecutive days, tail amputations or crush injuries were performed on 10 adult fish 
each. Both techniques were performed as described in Materials and Methods, at the level 
of the most proximal bifurcations in the tail. Crush injury was performed at 4 rays in each 
tail, 2nd and 4th from dorsal and ventral sides of the tail. On the 8th day, fish were humanely 
culled following the Schedule 1, Act 1986 Code of practice regulations. Their tails were 
collected, halved (separating two tail lobes from each other), fixed in 4% PFA and stored in 
100% methanol at -20˚C. Specimens were grouped according to the amount of days of 
post-injury recovery, e.g. 1 day post crush (1dpc) or 1day post amputation (1dpa). For each 
ISH experiment, four tail lobes of amputated tails were put together with four of the ones 
holding crushed rays at each collected time points of post-injury recovery 1-7days post (1-
7dp). Representative images of results can be seen in fig1.12 A. 
1.3.3. Osteogenic markers are expressed during bone 
crush repair as well as in blastemal outgrowth 
Sousa et al. (2012) developed a zebrafish fracture model performed on rays of the caudal 
fin. They showed that several skeletogenic markers are expressed after crush injury and 
have summarized that skeletogenic response was delayed in the crush as compared with 
amputation. I decided to check this more extensively, investigating not only 1 and 2 day 
post amputation/crush (dpa/c) as Sousa et al. (2012) did, but every day up to 7dpa/c 
(fig1.12). I used skeletogenic markers stated in the publication as my starting point, 





Figure 1.12 Temporal progression of osteogenic genes expression in injured zebrafish tails   
A) Whole mount in situ hybridization results showing osteogenic genes expression 
throughout 7days time course of zebrafish tail recovery after crush or amputation (amp).  
Scale bar corresponds to 100 µm in all panels, n=8 
B) Graphic representation of time point of certain markers appearance, identified by 
colours of names allocated in panel A  
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1.3.4. Skeletogenic genes expression patterns 
Collagen type 1 alpha 1a (Col1a1a) presence was detected in the crush site as early as 1dpc 
(Fig 1.12A, Col1 crush) while following amputation, detection was possible only at 2dpa (Fig 
1.12A, Col1 amp 2dp). Col1a1a expression in the crush site on 1dpc was loosely scattered 
around the crush area covering mainly ray parts adjacent to the crush. By 4dpc, temporal 
progression showed directed staining condensation towards crush plane, a transverse axis 
through the crush. 5dpc showed clearance of expression from the centre of the crush. On 
6dpc expression was detected particularly in the periphery of the crush area, forming an 
oval shape around the crush site, whilst by 7dpc staining was almost gone. In the 
amputation case, light staining came on 2dpa at the amputation plane. 3dpa showed strong 
staining of the tissue expanding distally from the amputation plane. On 4dpa, staining was 
seen on the distal ridge of newly formed outgrowth and this pattern continued to be 
detected till 7dpa with additional inter-segmental staining on 7dpa. 
Collagen type 10 (Col10) was upregulated as soon as 3dpa/c (Fig 1.12). The difference in its 
expression between crush and amputation lay not in the timing of the appearance but in 
the pattern of expression. In the fin outgrowth after amputation, col10 seemed to reside in 
the nascent bony rays formed in the blastema. Expression increased towards the distal end 
of the nascent bone, marking mainly the tip of newly formed rays (fig 1.12A, col10 amp). In 
the crush, it appeared from the proximal side of the crush on 3dpc and moved towards the 
centre of the callus by 5dpc, where it was detected until 7dpc (fig 1.12A, col10 crush). It 
should be noted that in zebrafish col10 is marking both, cartilage (Casar-Borota et al., 2016) 
and bone (Fang et al., 2016). 
Osteocalcin (bglap) expression was detected from 4dpa/c onwards. Osteocalcin expression 
appeared at the base of the outgrowth of the amputation and on the proximal bone 
adjacent to the crush, which might indicate directions from which osteoblasts were 
recruited to the site of injury. Staining progressively expanded distally during outgrowth 
after amputation (fig 1.12A, bglap amp). In the crush, injury staining appeared broadly 
spread on the crushed rays but not in the crush site at 4dpc. Over time spatial distribution 
changed from broadly spread across a few segments around the crush site to tightly 
encapsulating the crush itself (fig 1.12A, bglap crush).  
Osteopontin (spp1) expression upon the crush injury was observed as soon as 1dpc as 
scattered single cells around the crush site, both on the rays and also in the area 
surrounding them. By 2dpc staining appeared strong and crush localized, however, some 
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cells were stained also adjacent to the crush segment joints. 3, 4 and 5dpc staining appear 
much weaker with the second wave of strong upregulation by 6dpc appearing directly at 
the crush plane (fig 1.12A, spp1 crush). In the blastemal outgrowth after amputation 
staining appeared in the rays at the amputation plane and in loosely scattered cells in the 
blastema at 2dpa. Expression persisted until 3pda, but from 4dpa onwards its appearance 
became localized to the inter-segmental junctions in regenerated rays. From 5dpa onwards 
additional staining was detected at the tip of forming rays (fig 1.12A, spp1 amp). 
Based on these early stage experiments, similar trends in the bone markers in response to 
bone injury in the crush as well as in amputation were observed. However, ranges of 
differences, spatial as well as temporal (fig 1.12B) were noted. Encouraged by these results, 
further amputations to crush healing comparisons were performed, focusing on cellular 
contribution to those healing processes.  
1.3.5. Fibroblasts do not contribute to crush healing 
As Homeobox msx genes were previously proposed as markers of the blastema (Akimenko 
et al., 1995), I decided to use them to check if crush injury activates blastema marker 
expressions. I decided to use msxC, as its expression in blastema was already established 
(Ng et al., 2014). Moreover, In larval zebrafish fins, msxC marks fibroblasts, which later 
contribute to adult lepidotrichia (Lee et al., 2013) in chick developmental studies msx genes 
also were suggested as fibroblasts markers (Akiba et al., 2001). Therefore, I was interested 
to find out if fibroblasts take part in crush regeneration. Another two genes, hmcn2 and 
fbln1 known to mark fibroblasts (Lee et al., 2013) were tested along with msxC (fig 1.4).  
Surprisingly, none of the three genes show expression in the crush regeneration while all of 
them are expressed in the blastema outgrowth (fig 1.4). msxC showed similar expression 
pattern to hmcn2. Expression appeared as soon as 2dpa at the amputation plane. On 3 and 
4dpa it becomes broader along the proximo-distal axis, yet moved together with blastema 
outgrowth to the distal tip of developing rays. By 5 and 6dpa staining moved to the distal 
ridge of blastema, yet still appeared very strong. Staining of fbl1 was weaker and more 
localized although the pattern remains very similar to the other two genes. It appears on 
2dpa, becoming stronger, localized at the tip of newly formed rays at 3dpa, and moving to 




Figure 1.13 Fibroblast do not take part in crush recovery 
Whole mount in situ hybridization results showing fibroblast markers expression 
throughout 7days time course of zebrafish tail recovery after crush and amputation (amp). 
Yellow arrow shows blastemal outgrowth at the incident of ray loss, white arrow indicates 
lack of distal part of broken ray. 
Scale bar corresponds to 100 µm in all panels, asterisks indicate crush injury sites, n=8 
 
It is important to mention that small blastema formation was observed after loss of distal 
part of ray following some of the crush injuries (fig 1.13, msxC crush 3dp). Blastema is 
known to be formed after fin amputation (Adamski et al., 2014) as well as individual rays 
loss (Abel et al., 2014). Studies showed blastema formation after surgical removal of a few 
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segments of the ray (Abel et al., 2014). Data showed that small blastema can also be 
formed as a result of bone fracture (yellow arrow in fig 1.13, mscC crush), where 
lepidotrichia distal to the crush are lost (white arrow in fig 1.13, msxC crush 3dp). Recovery 
undergoes through blastema driven regeneration. The reason for the loss of ray in a 
number of circumstances is unclear. More information about ray loss after the crush is 
provided in chapter 4. 
1.3.6. Zebrafish crush repair phases mirror those of 
mammalian fracture repair 
As I determined that crush injury does not form a blastema nor repair via epimorphic 
regeneration, unless the broken ray get lost. I asked what might be the mechanism 
underlying bony ray healing after the crush. I decided to look for stages of mammalian 
bone fracture recovery in our crush model.  
Mammalian fracture repair follows 4 stages of recovery: inflammation, soft callus 
formation, hard callus formation and remodelling (Schindeler et al., 2008). I decided to 
check if those four stages can be detected throughout zebrafish ray crush healing.  
1.3.6.1. Stage 1 – inflammation 
I checked two types of inflammatory cells: macrophages and neutrophils. I used whole 
mount in situ hybridization (ISH) of Interleukin1 (il1) to a mark inflammatory cells. Probe of 
il1 was previously described as marker for inflammatory cells (Ogryzko et al., 2014) and it 
was shown to mark cells in first 24h post injury. I performed ISH for il1 on tails which were 
collected 1, 2, 4, 8, 12, 16, 20 and 24hours post crush (hpc) with 4 lobes per time point. 
Results of ISH were confirmed with neutrophil-specific Tg(mpx:GFP) transgenic zebrafish 
line, which was imaged at 5min post crush (5mpc) and 3, 7.5, 10.5, 15.5, 25.5, 72hpc. Fig 
1.14 B shows changes in cellular movement around the same crush in described range of 
time points.  
Inflammatory cells were recruited to crush site as soon as 2 hours after injury and the peak 
of il1 was detected 8hpc and remains very strong until 12hpc (fig 1.14A). Results from 
Tg(mpx:GFP) signal display a similar time points for neutrophils recruitment, however, 
fluorescent cells are detected in the crush for longer, up to 15.5hpc, suggesting that 
recruited leukocytes persist in the crush but do not activate interleukin gene expression 
anymore or that GFP perdured in cells longer that il1 mRNA. Both of the markers were 
cleared from the crush site by 24hpc, with the interesting phenomenon of explicit exclusion 




Figure 1.14 Inflammation stage in crush injury appears almost immediately after the 
crush 
A) il1 whole mount in situ hybridization marking inflammatory cells within the crush sites 
throughout the first 24hpc, timing first cells appearance for 2hpc and peak of inflammatory 
response for 8-12hpc, n=8 
B) Tg(mpx:GFP) crush time course showing neutrophils recruitment to the crush site and 
very strong clearance from the crush site by 72hpc, n=8 
C) graphical representation of zebrafish tail with introduced crush injuries marked as red 
crosses. Purple rectangular represent area which was imaged in panel A and green 
rectangular represent area which was imaged in panel B 
Yellow lines indicate crush plane. Scale bar corresponds to 100 µm in all panels in A, and 




1.3.6.2. Stage 2 – cartilage callus formation 
Cartilage callus formation is an important element stabilizing the fracture site. It is more 
flexible than bone, allowing alignment of two parts of the broken bone. However, it is rigid 
enough to keep broken parts in one place, preventing further disruptions of neighbouring 
tissues. Cartilage callus formation was tracked here by Alician Blue staining. Alcian Blue 
stains acidic polysaccharides such as glycosaminoglycans in cartilage, allowing temporal 
analysis of cartilage formation (Walker and Kimmel, 2007). Several protocols for Alcian Blue 
combined with Alizarin Red were tried (fig 1.15) but double staining made it difficult to 
distinguish between stainings and to determine staining intensity. Therefore, Alcian Blue 
single staining was performed for optimal effect. Staining shows clearly marked callus at 
4dpc. Blue stain becomes incorporated into the ball of tissue encapsulating the crush. The 
process of callus formation seems to start at 3dpc and persist until at least 5dpc.  
Cartilage formation might seem slightly controversial to be observed in dermal bone repair 
as dermal bone is believed to be produced through intramembranous ossification 
(Santamaria et al., 1992), which does not contain cartilage formation step (fig 0.10). 
Therefore, I went to the literature to find a possible explanation for this phenomenon. 
Upregulation of chondrogenic markers in blastema was previously reported by Smith et al. 
(2006). Encouraged by those findings, I decided to check chondrogenic markers in the crush 
as well as after the amputation. It was shown that paralogs of chondrogenic genes might 
play an important role (Duran et al., 2015), therefore I checked both, a and b versions of 
sox9 and col2a1 genes (fig 1.16). 
Expression of paralogs of sox9 as well as col2a1 can be found in the crush as well as 
amputation cases (fig 1.16). Staining appeared weak, despite the prolonged time of stain 
development indicating either: low amounts of mRNA present in the specimen or just a 
weak and ineffective probe. However, I rejected the second possibility by testing probes in 
developing zebrafish embryos as a control while staining tails. Embryo stain was strong and 
cartilage specific and compared to previously published patterns (Thisse, 2005). Both 
paralogs of sox9 were noticed in the blastema at 3dpa, however, the only sox9a appeared 
in the crush on 3dpc. Sox9 staining was very faint and inconsistent across the samples, 
therefore it was hard to determine chondrocyte presence based on it alone. Col2a1 
staining, despite also being faint, was more noticeable in the crush and amputation. 
Interestingly, the spatial distribution of the stain differentiates both the paralogs from each 
other. Col2a1a appeared distally to the crush, while col2a1b was present directly at the 
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crush site, where cartilage callus was getting formed. Col2a1b was stronger than col2a1a in 
the distal amputated fin (fig 1.16). 
 
Figure 1.15 Differences between 3 cartilage staining protocols 
A) Standard combined Alizarin Red and Alcian Blue protocol showed very strong 
overlapping staining of tissues, which made it impossible to distinguish between cartilage 
and bone calluses formation stages 
B) Two-colour acid-free cartilage and bone stain, initially developed for zebrafish larva 
staining (Walker and Kimmel, 2007) appeared extremely week for adult bone, therefore 
distinguishing between bone and cartilage was not possible. Interestingly, we observed ray 
loss in 3dpc sample, where two tissues were clearly distinguishable from each other 
C) Hydrochloric acid based solution stain appeared to be the most accurate for this 
experiment clearly reviling cartilage callus formation starting at 3dpc and forming rounded 
callus ball at 4dpc around the crush site 




Figure 1.16 Temporal progression of chondrogenic genes expression  
Whole mount in situ hybridization results showing cartilage formation markers expression 
throughout an 8days time course of zebrafish tail recovery after crush and amputation 





1.3.6.3. Stage 3 – hard callus formation 
Hard callus (bony callus) was formed by ossification of the cartilage callus. At that stage, 
cartilage callus seems to work as a scaffold for osteoblasts to deposit mineralised tissue on 
(Slowik and Bermingham-McDonogh, 2013). I performed Alizarin Red staining (separate 
from Alician Blue) (fig 1.17A). Alizarin red stains mineralized tissues, therefore all bony 
elements are stained red from 1dpc, however, strongly stained new bone deposition is 
clearly distinguishable from old bone, starting from 4dpc, when mineralized tissue starts to 
be laid around the crush and fracture edges. Ossification of the callus became obvious from 
5dpc onwards (fig 1.17A).  
 
Figure 1.17 Stage 3 – hard callus formation clearly noticeable from 5dpc 
A) Alizarin Red stain on fixed crush tissue from 1dpc to 8dpc 
B) Tg(osx:mCherry) transgenic line marking osterix in bone laying osteoblast accumulated 
around forming callus  
C) graphical representation of zebrafish tail with introduced crush injuries marked as red 
crosses. Pink rectangular represent area which was imaged in panel A and red rectangular 
represent area which was imaged in panel B  
Scale bar corresponds to 50 µm in all panels in A, and 100µm in all panels B 
Together with chemical bone stains, I observed osteoblast recruitment to crushes by use of 
transgenic lines. I attempted to create two transgenic lines, Tg(osx:Kaede) and 
Tg(osc:Kaede) to mark respectively early and late osteoblasts in vivo. Unfortunately, I did 
not succeed to obtain founders with good expression level. Therefore, I used 
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Tg(osx:mCherry) (Renn and Winkler, 2009) which showed good fluorescence in the crush. 
By using this line, promoter induction in osteoblast recruitment to the crush site was 
observed as early as 3dpc, forming strongly fluorescent bulky callus by 7dpc, and which 
faded away by 14dpc (fig 1.17B).  
These results, together with skeletogenic markers, marked by ISH shown in Figure 1.12, 
allowed us to time stage 3 occurrence for approximately 4dpc to 8dpc. However, 
mineralised matrix continued to be deposited beyond this point and osteoblasts were still 
active, as they play an active role in the remodelling stage. 
1.3.6.4. Stage 4 – remodelling 
In order to evaluate remodeling of bony callus, crushes were stained with Alizarin Red S, 
allowing tracking callus formation and re-formation (fig 1.18A). Callus sizes were measured 
in AxioVision software. The width of the callus was measured in µm and normalized against 
the width of an unbroken part of ray, of a segment proximal to the crush, to control for ray 
width differences between individuals and to obtain actual callus sizes. The region of 
measurement was indicated by white brackets in fig 1.18A, where 1 indicated width of 
unbroken bone in adjacent segment. Therefore, callus size was presented and plotted on 
the chart as a fold of unbroken bone (fig 1.18C). According to these data, width of 
mineralized callus at 5dpc is approximately 1.4 proportion of unbroken bone and it was 
progressively reduced over time. By 14dpc callus size was significantly reduced as 
compared to 5dpc and continued to be reduced with the time (fig 1.18A, C). Significance 
was checked by one-ways ANOVA using GraphPad Prism 7.01 program. 
Osteoclasts, bone resorbing cells play the main role in bone remodelling. They bring back 
the original bone shape through trimming away bony callus. I used cathepsin K (ctsK) as an 
osteoclast marker and through ISH I was able to determine when the expression of ctsK is 
enhanced, showing us osteoclast recruitment to the crush site (fig 1.18B). CtsK stain 
appeared as soon as 1dpc and was highly localised to the crush site. 2dpc staining remains 
strong, however, its localisation changed to the crush peripheries. By 3dpc staining 
intensity decreased, however, it risen again in the second wave of upregulation at 10dpc. It 
appeared crush localized and remained in this position through 13, 16, and 19dpc. By 
22dpc staining intensity was decreased again.   
CtsK upregulation in the 1st and 2nd day post crush suggests high bone resorption on those 
two time points. Due to my observations osteoclasts worked then to clear the crush site of 
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bone debris scattered around the crush, formed in the process of bone crushing. Osteoclast 
active between 13 and 19dpc was presumably trimming bony callus away. 
These data were consistent with the TRAcP staining on those time points performed by my 
colleague from Roehl lab, Luis Medina Sanches. 
 
 
Figure 1.18 Remodelling takes place from 9dpc onwards 
A) Alizarin Red S in vivo staining marking newly formed bone, white brackets show the way 
how callus was measured 
B) ISH results showing cartilage formation markers expression throughout 7days time 
course of zebrafish tail recovery after crush 
C) callus size shown as a fold of unbroken bone * p<0.05 ** p<0.01, ANOVA, n=8 





1.4. Discussion  
1.4.1. Unlike amputation, crush injury in zebrafish tail 
does not heal through epimorphic regeneration 
Based on the results presented in this chapter I state that process of healing after crush and 
after amputation significantly differ from each other. Unlike amputation, crush healing did 
not undergo epimorphic regeneration through blastema formation. I was not able to detect 
blastemal markers through 7 days post crush recovery, whilst blastema markers were 
strongly expressed after amputation (fig 1.13). Additionally, mini blastema formation after 
loss of distal part of the broken ray (fig 1.13, yellow arrow) supported my interpretation 
that two mechanisms of healing can work interchangeably depending on the severity of the 
injury. In support of this, Abel et al. (2014) showed that not only amputation can cause 
blastema formation, but also the removal of a few segments of an individual ray. I propose 
the presence of a mechanism detecting the severity of an injury, which directs and triggers 
adequate type of healing. Inflammatory cells have been previously shown to be able to 
sense tissue damage (Chen and Nunez, 2010) and activate and recruit different cell types to 
the injury site such as osteoblasts or osteoclasts, through cytokines such as il1 and il6, as 
well as growth factors, such as TNFs, PDGFs and VEGFs (Pape et al., 2010), therefore I 
propose that they are responsible for this mechanism. 
1.4.2. Crush injury in zebrafish tail heals through 4 
stages of fracture healing 
I focused on understanding the process of crush healing in the rays of the fish tail. I aimed 
to reveal organised, step by step mechanism which follows crush injury. I found, that it 
precisely followed previously described four stages of mammalian fracture healing model 
(Slowik and Bermingham-McDonogh, 2013).  
1.4.2.1. Stage 1 - inflammation 
Inflammation was reported by il1 ISH staining marking neutrophils and macrophages 
(Ogryzko et al., 2014). In addition, I used in vivo time series of Tg(mpx:GFP) possessing 
fluorescently labelled neutrophils. Results of both assays overlap, giving a strong indication 
of the inflammatory response in the first 2dpc. Inflammatory cells were clearly excluded 
from the crush site by 3dpc. It is interesting to compare it with previously published 
amputation data, where inflammatory cells were reported to reside at blastema for up to 
7dpa (Petrie et al., 2014). Possible explanations for faster inflammatory cells clearance in 
the fracture site might be correlated to the size of the wound, indicating area exposed for 
external factors which could determine the time needed for total clearance of pathogens 
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and debris form the injury site. Another explanation for fast inflammatory cells removal 
from fracture site might be physical exclusion of inflammatory cells by forming callus. This 
poses an interesting research question if prolonged inflammation, for example through an 
infection, can delay or block callus formation and the repair process (more information in 
Chapter 4). 
1.4.2.2. Stage 2 – cartilage callus formation 
Firstly, I presented cartilage callus formation by Alcian Blue staining, which marks cartilage 
glycosaminoglycans. Cartilage formation in the dermal bone of zebrafish tail is a 
controversial topic, previously mentioned in several publications (Smith et al., 2006). This 
problem was addressed in Smith et al. (2006) research on regeneration outgrowth after tail 
amputation, where chondrogenic markers, like sox9 and col2, were present in blastema. 
Those findings were evaluated in Duran et al. (2015) where evidence of chondrogenic 
markers presence was shown by ISH on sections of developing blastema. I used these 
markers to evaluate cartilage callus formation following crush injury in the zebrafish tail. I 
performed ISH on a time course of amputation recovery and also crushed specimens to 
give a full picture of cartilage forming potential. My results supported previously published 
findings of chondrogenecity in recovering injury in zebrafish tail. Staining for col2 and sox9 
in blastema formed after amputation was noticeable, however, weak staining and 
background reduced the clarity of the results. ISH repetitions with different experimental 
conditions did not improve results, indicating that the amount of cartilage formation is 
probably low, as found previously (Smith et al., 2006, Duran et al., 2015). Cartilage marker 
staining after crush injury was much more defined and localised to the injury. I conclude 
that cartilage callus formation in the zebrafish tail crush healing can be considered a 
distinct and independent stage of recovery. In order to improve the quality of results, 
future ISH could be performed on criosections as demonstrated in literature (Duran et al., 
2015, Smith et al., 2008). 
1.4.2.3. Stage 3– hard callus formation 
Hard callus formation was initially examined by ISH stainings of known osteogenic markers, 
such as bglap, spp1 and osx. All of them mark stages of osteoblast development and their 
successive appearance allowed understanding of recruitment and maturation of osteoblast 
throughout hard callus formation. I evaluated changes in spatial distribution of staining 
throughout the temporal progression of the healing process. Osteogenic markers were 
strongly upregulated throughout recovery after crush. Col1 and spp1 staining appear as 
soon as 1dpc followed by the appearance of col10 and osx on 3dpc and bglap on 4dpc. This 
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indicated that osteogenic processes are triggered as soon as 1dpc injury, probably by 
residing osteoblasts. By 3dpc osx and col10 markers were visible at the crush site, 
indicating recruitment and differentiation of new osteoblasts. Their maturation activated 
bglap, which I noticed at the crush site 4dpc. All osteogenic markers remained expressed 
till 7dpc, indicating that bone deposition takes place continuously. It is important to 
mention that osteoblasts are required at callus mineralization stage as well as in 
remodelling (Slowik and Bermingham-McDonogh, 2013). Therefore, we were not able to 
determine the time point of the finish of stage 3, yet know start time point and time point 
of stage 3 peak performance. Moreover, Alizarin Red, Alizarin Red S, and Calcein stainings 
indicated mineralized tissue deposition around the fracture site forming a hard callus. 
Callus growth indicated hard callus formation stage and narrowing of the callus indicated 
initiation of the remodelling stage. 
1.4.2.4. Stage 4 - remodelling 
Remodelling is the 4th and the last stage of fracture healing. Osteoclasts, working 
antagonistically to osteoblasts, are the main cell type involved in this step. Remodelling is 
based on bony callus resorption. The importance of osteoblasts should not be underrated 
as the remodelled bone has to be laid down after osteoclastic resorption. The ratio 
between anabolism and catabolism of bone in this recovery stage is shifted towards 
catabolism, since the overall outcome is a reduction of bone callus mass. I examined 
osteoclast presence by cstK ISH, known as an osteoclast marker. Osteoclasts recruitment to 
the crush site was seen as early as 1dpc. This can be explained by the presence of bone 
debris scattered around the crush site. Debris form due to crush injury, therefore, 
osteoclasts are recruited early in the healing process to remove debris and to smoothen 
rough edges of the broken bone, preparing the broken bone fragment for re-joining. From 
a cellular point of view, it was shown that osteoclast possess il1 receptors on their surface 
(Boyle et al., 2003).Therefore they are sensitive to the activation of inflammatory response 
by inflammatory cells, which I observed in stage 1. After initial upregulation of ctsK, staining 
signal reduces until 10dpc when it re-appears. I predicted that this is the time when callus 
remodelling takes place. Staining persists in place until 19dpc and is much reduced by 
22dpc. I observed the reduction in bony callus size until at least 38dpc, suggesting 
remodelling occurs continuously until at least this time point, and probably beyond as the 




Figure 1.19 Graphical representation summarising 4 stages of crush healing in zebrafish 
ray  
A) Example of techniques used to indicate each stage 
B) Qualitative readout of markers expression  
1.4.3. Four stages are easily distinguishable yet highly 
overlapping in temporal progression  
Based on my results I was able to show a temporal distribution of all stages (fig 1.19). All 
stages overlapped, probably due to high molecular cross-talk between tissues and cells. 
Markers of all stages appear gradually. This phased response mimics results seen in 
mammalian models (Slowik and Bermingham-McDonogh, 2013). Zebrafish recovery time 
was twice as fast as the time reported in rodent animals. In rodent models, such as mice, 
the inflammatory stage can take up to 7 days, peak of cartilage callus formation was timed 
at 7-9days post trauma, peak of hard callus formation set as 14dpc and recovery usually 
starts not earlier than 3-4week post crush and take years to be fully finished (Einhorn, 
1998, Marsell and Einhorn, 2011). The zebrafish crush model presented here cuts the 
required research time in half. Inflammation completely cleared from crush site by 3dpc, 
cartilage callus stage was timed for 3 to 5dpc and peak of hard callus formation lies around 
7dpc.  
1.4.4. Crush injury is a reliable and adequate model for 
human bone fracture 
According to the results presented in this chapter, I showed that the crush model in the tail 
of zebrafish undergoes the same stages of regeneration as previously described in the 
healing of breakages in mammalian bones (Bostrom et al., 1995, Slowik and Bermingham-
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McDonogh, 2013). With all the advantages of using zebrafish in biomedical research, this 
field could be easily expanded. I believe that presented here crush model can serve as fast 
and accurate fracture model allowing understanding of fracture healing at cellular and 
molecular level.  
In addition, the crush model is able to help in understanding the impact of drugs or genetic 
diseases on fracture healing. By simply measuring differences between treated, untreated 
or disease affected individuals, we can determine which step of healing is perturbed. 
In the following chapters, I am presenting the full range of examples showcasing the 
importance of zebrafish crush model in biomedical research. These range from experiments 




2. Chapter 2 – Fracture healing in 
an Osteogenesis Imperfecta Model 
2.1. Introduction 
2.1.1. Osteogenesis imperfecta  
Osteogenesis imperfecta (OI), also called brittle bone disease, is a genetic disease mainly 
characterized by high bone fragility. Other phenotypic traits include blue sclera, impaired 
hearing, skeleton deformity, and dentinogenesis imperfecta (Forlino et al., 2011). OI is a 
highly diverse disease in term of genotype and phenotype. Currently, 15 different types of 
OI can be distinguished (Valadares et al., 2014), out of which the first four are caused by 
mutations in collagen I genes and differ from each other by the strength of symptoms. Type 
I is very mild with rare spontaneous fractures and mild skeleton deformations, whilst type II 
is the most lethal one. Children with type IV OI are born with many deformations of 
skeleton, numerous fractures of long bones, and a narrow chest with broken ribs, leading 
to premature death, usually due to inability to breathe. Based on malformations severity, 
types III and IV lay in between types I and II, with moderate strength of phenotype. An OI 
classification scale was made over 3 decades ago by Sillence (Sillence et al., 1979) and has 
been kept up to date as a guideline for assignment of OI types. Types V to XV are caused by 
mutations in non-collagen genes and usually are phenotypically compared to one or two 
phenotypic profiles out of four described by Sillence’s division (Galicka, 2012). Genes 
mutated in types V to XV codes collagen-related proteins and correspond to either collagen 
chaperones or foldases encoded by SERPINH1 and FKBP10 (OI type Xl); collagen modifiers, 
e.g. components of 3-Hydroxylation Complex encoded by CRTAP, LEPRE1, PPIB (OI types 
VII, VIII and IX); collagen mineralization proteins encoded by SERPINF1 and IFITM5 (OI type 
V and VI); and collagen structural processing protein encoded by BMP1 (OI type XII) (Marini 
et al., 2014). The focus of this thesis is type XII with mutations in BMP1 gene.  
2.1.2. Role of BMP1 in bone formation context 
Bone morphogenetic protein-1 (BMP-1) is a tolloid-like metalloproteinase that plays a 
crucial role in osteogenesis (Asharani et al., 2012). In addition, it processes non-osteogenic 
related extracellular proteins like probiglycan, prolysyl oxidase, the γ2 chain of laminin-5 
and chordin as well as in activating other bmp family proteins like BMP2 and BMP4 (Perren 
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et al., 1975). For the purpose of this study, my focus was shifted towards its importance in 
bone as well as cartilage formation by cleavage of C-terminus from procollagen precursors. 
C-terminus cleavage is crucial for precise collagen fibril formation (McKibbin, 1978), in 
particular, Col1, which is the main building element of osteoid and col2 of cartilage. Bmp1 
was shown to cleave procollagens precursors for both of these proteins, as well as other 
collagen types (Perren et al., 1975).  
2.1.3. Spontaneous fractures and bone healing problems 
in OI patients 
OI patients are well known for being prone to spontaneous bone fractures (Forlino et al., 
2011). OI fractures display healing problems, delaying recovery or unabling fracture joining, 
creating non-union fractures (Gamble et al., 1988). OI fractures often lead to severe bone 
deformations, which express the need for surgical corrections (Anam et al., 2015). 
However, osteotomy performed on malformed OI patient bones, often also fall into slow- 
or non-healing category (Munns et al., 2004), the explanation for this are not known. 
Clinicians wish to understand details of OI fracture healing, therefore need for the animal 
model of OI fracture creation was expressed (Anam et al., 2015).  
2.1.4. Animal OI models  
Previously reported spontaneous animal OI cases, including dogs (Campbell et al., 2001), 
cats (Evason et al., 2007) and recreated mutogenetically mice (Chipman et al., 1993) proved 
that this human disease can be easily modelled in animals. OI mouse models have been 
researched for over 2 decades, with most of them arising from mutagenic screens and 
exhibit mutations in collagen 1 genes, leading to mimicking OI types I to IV (Khillan et al., 
1991, Pereira et al., 1993). A recent boom of genome modification tools, allowed 
researchers to create mouse mutants with desired mutations in col1, e.g. Brtl/+ murine 
model for OI type IV (Forlino et al., 1999) as well as other genes like IFITM5, mimicking OI 
type V (Lietman et al., 2015) . Unfortunately, the Bmp1 mouse mutant was perinatal lethal, 
therefore creating mouse model of OI type XII became a challenge (Suzuki et al., 1996). In 
order to create Bmp1−/− murine mutant, Bmp1 was conditionally targeted in order to 
induce postnatal ablation and avoid the prenatal lethality of Bmp1−/− (Muir et al., 2014). 
Null mice presented typical for OI phenotype including weak and brittle bones, 
spontaneous fracture formation and other skeletal features such as porous cortical bone 




2.1.5. Zebrafish OI mutants 
Mutagenesis screens in zebrafish revealed several bone mutants, which have been shown 
to constitute OI model. These include severe and mild col1a1a mutants Chihuahua (chi)  
(Fisher et al., 2003) and microwaved (med) as well as frilly fins (frf) (van Eeden et al., 1996). 
The latter was identified as a bmp1a mutant and modelled a form of OI due to mutations in 
BMP1. Fish characterization was performed and compared with human BMP1 deficient 
patients showing striking similarities (Asharani et al., 2012). frf possessed fragile bones 
prone to spontaneous fractures, with elevated mineral density. 
2.1.6. Aims of experiments shown in this chapter 
Fractures of frf mutants were not assessed previously for healing ability and were not 
compared to human fracture healing ability, and this is the aim of experiments in this 
chapter.  
2.2. Materials and methods 
2.2.1. frf fish alleles used 
4 different alleles of frf mutant fish were used. They were previously mapped and 
described by Asharani et al. (2012). frfty69 possessed missense mutation within the protease 
domain affecting conserved amino acids, frftp34 possessed nonsense mutation that 
truncated the protein at the end of the proteolytic domain, frftm317 and frftf5 possessed 
splice-site mutations, where frftm317led to 21 amino acid long deletion from proteolytic 
domain and frftf5 created several erroneous splice products (fig 2.1) (Asharani et al., 2012). 
The range of mutant alleles provided range of phenotypical severity from frftp34 being the 
strongest allele, followed by frftm317, frfty69, and frftf5.  
 
Figure 2.1 Graphical representation of BMP1 domain structure. The locations of zebrafish 
mutations in frf were identified under the structure.  
Schematic view of BMP1 domain structure with indicated locations of identified zebrafish 
mutations. Note that the frf tf5 mutation generates multiple splice isoforms.  
Image adapted from (Asharani et al., 2012) 
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2.2.2. dCAPS screens for mutants 
Genomic DNA was extracted from scales of individual adult zebrafish as described in 
chapter 1, then diluted 1:1 with water and used for PCR reaction with tm317_dcaps 
primers (Table 2.1). Standard 10µl PCR reaction was performed with 1µl of diluted gDNA, 
1µl of each primer (from 10µM stock), 5µl of 2X GoTaq Green Master Mix (Promega 
M7122) and 2µl of Nuclease-Free Water. The reaction consisted of 35 cycles with 53°C 
annealing temperature. 
Name of the 
primer 
Sequence of the primer in 5’ to 3’ direction 
5’ -> 3’ 
tm317_dcapsf TTG TGT TTG TTT CTT GAC AGA GG T 
tm317_dcapsr GTT TTA AAG TCA ACA TAT GCG TAA TTC TCT CA 
Table 2.1 frftm317 dCAPS primers sequences  
After PCR reaction was completed, 2l NEB4 buffer, 1l MfeI enzyme (or 0,5 l MfeI-HF) 
and 7l H2O were added to each tube. The total 20l reaction was mixed and incubated for 
2h at 37°C to allow complete PCR product digestion. To examine digest results, the reaction 
was run on a 4% gel to allow accurate separation of DNA fragments. Wild type fish showed 
a 178 bp band, frftm317 mutants 146 bp and 33 bp fragments and frftm317/+ showed all three 
bands. 
2.2.3. Corrected total crush fluorescence measurements 
Corrected total crush fluorescence was used to measure fluorescent signal emitted by 
neutrophils in the crush area of Tg(mpx:GFP) fish. The protocol for corrected total cell 
fluorescence was adapted from (McCloy et al., 2014) where single cell fluorescence is 
measured in cell culture and normalized against the fluorescence of the background. I used 
the same methodology, however, I submitted cells with crushes. Fluorescent channels were 
separated using ImageJ and the crush area was defined using green channel (fig 2.2A). The 
same crush area was used for all time points, assuring consistency in measurements. All 
measurements were normalised against initial fluorescence detected at the crush site just 




Figure 2.2 Obtaining corrected total crush fluorescence 
A) defining measurement area indicating crush on 32bit images at different time points 
post crush 
B) CTCF calculated as a difference between measured fluorescence intensity and base 
fluorescence from the same place before the crush 
 
The original Corrected total cell fluorescence (CTCF) was calculated according to the 
formula: CTCF = Integrated Density – (Area of selected cell X Mean fluorescence of 
background readings) (McCloy et al., 2014). In here, CTCF (corrected total crush 
fluorescence) was calculated according to crush adjusted formula: CTCF = Integrated 
Density – (Area of selected crush X Mean fluorescence of 0hpc readings). Microsoft Excel 
was used for calculations (fig 2.2B)., results were transferred to Graphpad Prism 7 in order 
to create charts.  
2.3. Results 
I decided to check bone regeneration ability of OI zebrafish mutants. Asharani et al. (2012) 
describe that frf fish bone density is abnormal in both vertebral centra and fin rays, leading 
to bone fragility. It was shown that frf mutants, similarly to human OI patients, suffer from 
bone malformations and spontaneous bone fractures (Asharani et al., 2012). However, 
there was no data available on the healing of those fractures. Moreover, an ability of bone 
regeneration after amputation in frf fish mutants was not assessed. 
2.3.1. OI zebrafish maintain tail regeneration ability   
I decided to assess regeneration ability of frf mutants on the example of frfty69, one of the 
stronger mutant alleles. I assessed if the process of regeneration after tail amputation was 
normal in those fish despite bone related gene mutations. Tails of frf mutants were 
misshaped, often shorter and lacking normal fin shape. I examined blastema formation and 
tail regrowth following an amputation. The results showed that bmp1 mutation does not 
affect temporal outgrowth of lost tail. Blastema formation was observed as normal and 
outgrowth formation timing was comparable with wild type fish to 14 days (fig 2.3 A). The 
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shape of newly formed tail resembled the original. Rays at the dorsal lobe were tilted 
towards the middle of the tail instead of being spread distally.  
 
Figure 2.3 frf tail regeneration after amputation 
A) Bright field images of blastema formation and regeneration outgrowth of amputated tail 
of wild type (AB) zebrafish  
B) Bright field images of blastema formation and regeneration outgrowth of amputated tail 
of frfty69 zebrafish mutant  
C) degree of regeneration ability between different OI zebrafish models (frilly fins – frf and 
microwaved – med) and wild type fish (AB). Newly formed bone was consecutively stained 
with calcein and Alizarin Red S to assess the rate of bone deposition 
D) extreme case of mutant fish not able to perform tail regeneration after amputation 
Scale bar corresponds to 300 µm in all panels in A and B, and 100µm in all panels in C and D 
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To ascertain the ability of bone restoration in frf mutants, I assessed phenotypically more 
severe frf alleles. Interestingly, I found that the rate of overall tissue re-growth varies 
between alleles. While frfty69shows ability to restore the lost part of the tail as described 
above, in the frftp34, which contains a nonsense mutation, there was limited regeneration in 
some individuals. Lepidotrichia appears shortened, thickened and often joined with 
neighbouring rays (fig 2.3B). Some extreme cases show a complete fusion of outgrowing 
rays into one bone mass (fig 2.3C). Intra-allelic variability of regeneration was high, 
suggesting multigenic contribution.  
2.3.2. Tail of OI zebrafish is full of randomly distributed 
bone calluses  
Several spontaneous calluses were observed in adult frf zebrafish tails (green circles in fig 
2.4). These tissue accumulations can be observed using bright field microscopy (fig 2.4B), 
however, it is Alizarin Red staining which helped me to determine that calluses are formed 
from mineralized tissue (fig 2.4C). Breakages occur spontaneously, with the preponderance 
for proximal half of the tail. No repeatable breakage pattern was observed among the 
mutant fish, therefore their dorsoventral distribution can be described as random.  
 
Figure 2.4 frf fish tail is full of mineralized calluses  
A) tails of uninjured wild type and mutant fish exposing frf spontaneous fractures (marked 
by green circles) 
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B) magnifications of calluses on individual rays  
C) Alizarin Red S stained rays showing mineralized tissue deposition at the site of 
spontaneous fractures  
Scale bar corresponds to 300 µm in all panels in A, and 100µm in all panels in B and C 
2.3.3. Fractures in OI zebrafish tail heal less efficient 
than wild type fish 
Due to an inability to track repair of spontaneous fractures from the outset, I decided to 
introduce new fractures using our previously established crush model. This enabled us to 
track crush healing in OI model throughout all four bone healing stages.  
2.3.4. Stage 1 – inflammation 
2.3.4.1. il1 ISH reveals differences in spatial distribution 
In order to estimate inflammation intensity, we performed ISH at 8hpc and 12hpc using il1 
probe described previously in chapter 1. Choice of time points was based on results from 
chapter 1, showing the peak of il1 marked inflammatory response is at 8hpc and another 
visibly strong time point at 12hpc. 12hpc showed the slight reduction of stain intensity as 
compared to 8hpc in AB, but most importantly it presented different spatial distribution of 
marked cells, therefore I chose it as a second control time point. Both time points can be 
used as strong indicators of inflammation stage in crushed zebrafish rays. In both frf as well 
as AB fish, at 8hpc, inflammatory cells labelled by il1 invaded the fracture zone and 
accumulated at the crush plane (fig 2.5A, 8hpc). Crush planes in fig 2.5 were indicated by 
yellow lines. At 12hpc in wild type fish, the majority of labelled cells appeared on the 
outside of the fracture plane, covering ray segments adjacent to the fracture. However, in 
frf mutants, il1 labelled cells persist in the fracture gap until 12hpc (fig 2.5A, 12hpc). In 
summary, stain intensity reduction between 8hpc and 12hpc between frf and AB fish was 
comparable, however, spatial cells distribution in frf mutants does not remain consistent 
throughout temporal progression as compared to wild type fish. These results suggested 
that inflammation occurs with comparable rate but different cellular movement in frf 




Figure 2.5 Inflammation of crushes at frf fish 
A) Whole mount in situ hybridization comparison of il1 expressing cells between wild type 
fish and frf mutant at two time points 8 and 12hpc, yellow lines indicate crush plane  
B) neutrophils recruitment to the crush site and their spatio-temporal progression through 
86hpc imaged in transgenic lines Tg(mpx:GFP) between wild type and frf mutant fish, 
yellow lines indicate crush plane. Arrows indicate difference in neutrophils distribution. 
C) Graph representing temporal distribution of corrected total crush fluorescence for 
crushes of frf and sibs, showing no significant difference between the two, at any time 
point checked up to 86hpc, n=8 
Scale bar corresponds to 100 µm in all panels in A, and 50µm in all panels in B  
2.3.4.2. CTCF show no significant difference in the strength of 
inflammatory response 
To further evaluate inflammation in OI fish I crossed frf317 to Tg(mpx:GFP) to label 
neutrophils with GFP, in both mutants and siblings. Crush injuries were performed and fish 
were imaged at 9, 19, 24 and 86hpc (Fig.2.5B). In both, frf and sibs, inflammation markers 
were upregulated and clearly visible. In both, the peak of inflammatory cells recruitment 
appeared at 9hpc at the centre of crush plane, indicated by the yellow line, between two 
parts of broken bone (Fig.2.5B, 9hpc). By 19hpc neutrophils of sibling fish accumulated at 
the periphery of the crush, while those of frf mutant persisted in the center of the crush 
plane (Fig.2.5B, 19hpc). This cellular spatial distribution is consistent with the in situ 
hybridization data (fig 2.5A). In both frf as well as siblings, neutrophils were completely 
excluded from the crush area by 86hpc (fig 2.5B, 86hpc), which was consistent with wild 
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type fish data reported in chapter 1. To quantify those results I performed a set of 
measurements and calculated Corrected Total Crush Fluorescence (CTCF). CTCF was 
calculated based on measurements collected through analysis, in ImageJ, of crush images 
taken sequentially. Microsoft Excel was then used to perform CTCF calculation, according 
to the following formula: CTCF = Integrated Density – (Area of selected crush X Mean 
fluorescence of 0hpc readings). Pooled results from 8 experimental repeats were plotted 
using GraphPad Prism 7 (fig 2.5C). Corrected Total Crush Fluorescence (CTCF) at each time 
point was comparable between frf and sibs (fig 2.5C). Statistical significance was checked 
by paired t-test at each time point.  
No significant difference was found in CTCF between frf and sibs and the shape of the 
graph is comparable between frf and sibs. Thus, I can state that frf mutants show wild type 
immune response to the crush injury at all stages analysed.  
2.3.5. Stage 2 – soft callus formation 
2.3.5.1. Alcian blue stain reveals reduction in cartilage callus size in 
frf fish  
To examine soft callus formation, I performed alcian blue staining on crushes of frf317 
mutant as well as wild type fish. Temporal progression of cartilage callus formation was 
analysed, based on images of stained crushed fins from different time points following 
crush injury. Callus size was determined by the ratio of callus width, measured at the 
widest part of formed callus, to ray width measured in the middle of the segment adjacent 
to the broken one (red brackets fig2.6A). Results were plotted (fig 2.6B) and statistically 
tested by ANOVA. On 3dpc and 5dpc, the difference between callus sizes of frf317 and AB 
was statistically significant, with p values of 0.012 and 0.015 respectively. Therefore, to 
rigorously test obtained results, I repeated staining on other strong frf alleles: frftf5and 
frftp34 and compared their callus sizes to results obtained from AB fish at each time point. 
Statistically, the significant difference was reported from frftf5 results at 6dpc, with 
p=0.0464. To determine differences in cartilage callus sizes between different mutant 
alleles I compared them to each other but no significant difference was observed from 
those comparisons.  
2.3.5.2. Cartilage callus formation is not stopped in frf fish, yet 
callus size is significantly reduced 
As per column comparison at each time point, the size of cartilage callus was reduced in all 
mutant alleles, however, none of them showed consistent reduction throughout all time 
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points. Instead, the significant reduction on certain days was observed as compared to AB 
fish (fig2.6 B). Based on those differences in callus sizes between frf mutants and wild type 
fish I concluded that stage 2, cartilage callus formation, in mutant fish was slightly impaired 
as compared to cartilage callus formation in wild type fish, although not totally blocked.  
 
Figure 2.6 Cartilage callus formation is reduced in frf fish 
A) Alcian Blue cartilage callus staining. Red brackets indicate how the measurements were 
taken. Unbroken bone’s width was set as 1 and callus size was presented in proportion to 
this measurement. Scale bar corresponds to 50 µm in all panels  
B) cartilage callus sizes, measured as a ratio of callus width to the width of unbroken bone, 
ns=non-significant, n=8 
2.3.6. Stage 3 and 4 – callus ossification and remodelling 
2.3.6.1. Osteogenic markers ISH helps in osteoblast distribution 
patterning 
To ascertain the repair rate of bone, I decided to evaluate osteoblast presence in the crush 
site by ISH of osteocalcin (bglap) and osteopontin (spp1) on each day after crush, up to 
8dpc. By observing those osteoblasts markers, I could evaluate differences and similarities 
in osteoblast spatial and temporal appearance in the crush site between wild type and frf 
mutant fish. spp1 appeared in the crush site as soon as 2dpc and remained very strong until 
4dpc in frf and 5dpc in AB. It remained present in both 8dpc. In AB, staining was directly 
localized at the crush site and around the forming callus, while in frf it appeared at the 
broken segments, adjacent to the breakage, in the close proximity to the fracture plane, 
but not in the fracture plain. bglap, appeared very strongly in the callus as well as segments 
adjacent to the fracture plane in ABs, with expression moving to adjacent ray by 8dpc (Fig 
2.7A). In frf, expression initiated by 3dpc and its spatial focus does not change over time. It 
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followed the pattern of spp1 staining and stayed on crush periphery, instead of penetrating 
the fracture.  
2.3.6.2. Callus shaping process revealed by transgenetically 
labelled osteoblast tracing 
To further evaluate osteoblast distribution as well as callus ossification, I generated 
frf317;Tg(osx:mCherry) line with fluorescently labelled osteoblasts through the use of the 
osx:mCherry promoter (Renn and Winkler, 2009). By observing fluorescent osteoblasts 
encapsulating the callus (to mineralize it), the shape of the callus could be defined. While 
callus of wild type was nicely rounded around the fracture, encapsulating crush site and 
stabilizing it (fig 2.7B, AB), frf callus was much narrower. Fluorescence was reduced in the 
callus of frf mutants and labelled osteoblasts show different spatial distribution as 
demonstrated on densitometry graphs in fig 2.7C. While osteoblast fluorescence signal in 
crushes in AB fish came strongly at the callus periphery and as time passes fluorescence 
increased in the middle of the crush, osteoblast fluorescence in frf fish appeared overall 
weaker in intensity and more dispersed, giving a more even signal in the middle of the 
crush instead of sides of the callus. The shape of the area covered by osteoblasts in frf was 
much more challenging to define, compared to covering a rounded, mineralized callus in 




Figure 2.7 Osteoblasts recruitment to the crush site in frf fish  
A) Whole mount in situ hybridization of osteoblast markers (spp1, osc) expression  
B) comparison of osx marked osteoblast recruitment to perform callus ossification between 
transgenic lines of AB and frf mutants  
C) densitometry of cross-section through callus images, indicating staining intensity 
distribution across line annotated in panel B  
Scale bar corresponds to 100 µm in all panels in A, and 50µm in all panels in B  
2.3.6.3. Alternate bone staining allowed tracing progressive callus 
ossification 
Due to altered osteoblast distribution in the callus, I decided to assess bone deposition 
during crush repair process. To better delineate progressive bone deposition over time we 
stained bone through the alternate use of Alizarin Red S and calcein (fig 2.8A). This allows 
us to distinguish nascent bone deposition from the previously deposited bone. 
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2.3.6.4. Shape of frf mineralized callus was visibly distorted  
frf317 failed to form normal, ball-like mineralized calluses around breakage sites. Instead, 
chaotic bone joining was observed, in which bone matrix formed a thin connection 
between broken ends of the ray. Mineralization appeared delayed, while callus growth was 
reduced. This was quantified by measuring the width of the nascent bone at the fracture 
formed during repair process and normalized to adjacent, uninjured ray width (brackets in 
fig 2.8B).  
 
 
Figure 2.8 Mineralized callus formation is reduced in frf fish 
A) experimental setup of alternate calcein (green) and Alizarin Red S (red) bone staining 
following crush injury  
B) callus building progression with callus measuring method  
C) significant differences in relative callus sizes in all measured time points between wild 
type and mutants, ANOVA,  **** p<0.0001, n=16 
Scale bar corresponds to 50µm in all panels in B  
 
2.3.6.5. Size of frf bone callus was significantly reduced as 
compared to wild type fish  
At all time points measured, there were significant differences in mineralized callus sizes. 
Wild type fish showed mineralised callus at the crush site by day 5. It was slowly resolved 
during the remodelling process indicated on the graph by callus size reduction in following 
time points (fig 2.8C). In contrast, callus size in frf mutants is much smaller. The nascent 
bone formation is delayed, leading to delayed callus growth. Thus whilst wild type callus is 
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resolving, in frf fish the callus remains in a growth phase to 24dpc. This relative difference 
in callus dynamics is presented in fig 2.8C. 
2.3.6.6. Osteoclasts are recruited as normal 
In order to check all possible signs of remodelling, we examined osteoclasts recruitment to 
the crush site by ctsK ISH. Staining was seen at the dates corresponding to the standard 
ctsK temporal distribution of wild type fish reported in chapter 1. Staining came up as soon 
as 1dpc and remained at the crush site till 3dpc, then it was reduced until 10dpc when it 
came up again and remained till 22dpc (fig 2.9). 
 
Figure 2.9 Whole mount in situ hybridization for ctsK expression detection  
ctsK is expressed 1-3dpc and 10-22dpc in both A wild type fish (AB) and B frf317 mutants. 
Scale bar corresponds to 100 µm in all panels, n=4 
2.3.7. Non-union fractures  
Interestingly, I observed that a number of fractures failed to connect broken parts of the 
ray. I separated those from the pool of crushes, calculated their amount and investigated 
them separately under a non-union fracture category. I found that 30% of crush injury 
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cases in frf failed to form the connection between the broken rays, whilst it always occurs 
in wild type fish (fig 2.10A). The gap size changes were progressively measured over time 
and compared to the wild type control. I saw the significant difference in the gap size 
throughout the whole healing process between two groups at most time points (fig 2.10B). 
The gap between the rays following the crush injury was reduced rapidly in wild type fish as 
mineral tissue was deposited in the intra-fracture space. This gap in frf mutants perdured 
for at least as long as 24days (fig 2.10B, C). 
 
Figure 2.10 30% of frf crushes led to non-union fractures  
A) in frf mutants around 30% percentage of introduced crushes were not able to re-join by 
24dpc, n=24 
B) there were significant difference in gap sizes between wild type fish and mutants ** 
p<0.01 **** p<0.0001, n=7, ANOVA 
C) gap joining progression with gap measuring method indicated as red brackets, time 
series of the same fish 
Scale bar corresponds to 50µm in all panels in C  
2.4. Discussion 
In this chapter, I evaluated regeneration ability of zebrafish frf mutant, which represents a 
fish model for Osteogenesis Imperfecta (OI). I was able to show that despite their ability to 
regrow lost tails, frf bone crush healing ability was highly disrupted. Based on previously 
published frf characterization (Asharani et al., 2012), we knew that bone fragility and 
malformations occurred due to the mutation in bmp1, the procollagen C-proteinase, which 
caused kinked and disturbed collagen fibres formation.   
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2.4.1. frf fracture healing appeared to be strongly 
interrupted at the stage of hard callus formation 
By use of zebrafish crush model, I examined all 4 stages of fracture healing of tail crushes in 
frf mutant fish. All four stages were slightly disturbed in frf mutants indicating that OI is a 
systemic disease influencing a range of responses, important for correct response to the 
injury. However, based on presented here results, I was able to pinpoint stage 3 as the 
phase mostly affected by the mutation, with significantly elevated difference in bony callus 
size and shape between wild type and mutant fish.  
2.4.2. Stage 1 - inflammation 
The strong inflammatory response was present in both mutants as well as wild type fish. 
Spatial differences in inflammatory cells distribution were present, which could be 
explained by differences in bone quality influencing bone topography between two 
assessed fish types. There was no significant difference in Corrected Total Crush 
Fluorescence (CTCF) at any time point measured. CTCF of frf crushes was similar to the 
CTCF of wild type fish crushes. The Linear trend of fluorescence temporal progression 
showed the same distribution pattern between the two groups. As such, there is no real 
difference in inflammation stage between mutant and wild type fish. Both of them 
upregulate inflammatory markers around 8hpc, decrease it by 24hpc with total marker 
exclusion form the crush site by 86hpc.  
Based on these results, and lack of published correlations between bmp1a and 
inflammation, I state that stage 1 is not affected by mutation in bmp1 gene, due to lack of 
differences in inflammation seen between frf and wild type fish.  
2.4.3. Stage 2 – soft callus formation 
We have examined soft callus formation by Alcian Blue staining. Due to lack of the clarity in 
the results obtained from frf317 staining measurements, I investigated other frf alleles by 
Alician Blue. Results showed the general decrease in cartilage callus sizes in all assessed 
mutants, however, in none of these alelles callus size was significantly reduced at all time 
points. Therefore, I was not able to claim perturbance of stage 2 in frf crush recovery. I 
suspect that stage 2 was mildly affected. It is known that Bmp1 cleaves C-terminal of 
procollagen II (Moali et al., 2005) and mutations in Bmp1 lead to the lack of procollagen C-
terminal cleavage. That influence kinked and distorted collagen fibers formation, yet the 
formation still takes place. 
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I believe that in frf fish, due to Bmp1 mutation, collagen II fibers were not formed properly 
influencing the structure, shape, size and overall appearance of cartilage callus, although 
callus formation was not blocked. This might reflect tolerance of cartilage to malformed 
collagen II fibers. 
2.4.4. Stage 3 – hard callus formation 
Bony callus formation was assessed by osteoblast tracking as well as evaluation of 
progression of mineralized tissue deposition. Mineralized callus formation was significantly 
impaired in frf mutant, and if formed, appeared as a small and thin connection between 
the broken bone parts instead of forming a ball-like structure encapsulating and stabilizing 
the crush. 
I predict that lack of properly formed cartilage callus, which normally acts as a scaffold for 
osteoblasts to migrate onto, depositing mineralized tissue (Slowik and Bermingham-
McDonogh, 2013), reduces the possibility of formation properly shaped bony callus. In 
addition, mutations in bmp1 gene trigger distortion in collagen 1 fibers formation, which 
are the main component of osteoid, therefore mineral bone is affected. It was shown 
previously that in frf fish bmp1 mutation led to the lack of procollagens C-terminus 
cleavage and bone deformations (Asharani et al., 2012). We propose that generation of 
mature collagen l fibers in osteoid is critical for fracture repair and callus formation. 
Stage 3 of frf crush recovery was strongly affected in frf fish, due to perturbed cartilage 
template for osteoblasts to migrate, and to impaired collagen I fibers formation. 
Nevertheless, I believe that results seen in stage 3 display a collectively disruptive effect of 
combined disturbances in stages 2 and 3 together.  
2.4.5. Stage 4 – remodelling 
It was difficult to assess remodelling in a callus that was not even formed properly. I did not 
observe any reduction in callus size indicating remodelling up to 24dpc. It might be due to 
the fact that throughout the experiment, callus of frf did not reach the original width of 
unbroken bone, therefore remodelling was not triggered in those fractures. 
Osteoclasts were recruited to the crush site as normal in the time points corresponding to 
the osteoclast recruitment in wild type fish, therefore we can claim that cellular cross-talk 
between osteoblasts and osteoclasts is unaffected in frf fish. Moreover, I suspect that initial 
osteoclasts activity on 1-3dpc, together with disrupted ability for callus formation, might 
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contribute to bigger gap formation in between broken parts of the bone, and leading to 
enlargement of injury site.  
2.4.6. Crush in frf perfectly imitate crush healing in OI 
patients  
Based on the result, I can clearly state that the crush zebrafish model accurately mimics 
mechanism of crush healing in OI patients. Data showed that around 30% of fractures in OI 
zebrafish model do not join, precisely imitating OI human patients, as it was reported that 
around 30% of fractures in human OI patients lead to non-joining fracture type (Gamble et 
al., 1988) 
2.4.7. Crush model accurately assess impaired stage 
among 4 healing stages   
In this chapter, results confirmed our predictions that usage of zebrafish crush injury 
model, enable to determine which fracture recovery stage might be affected in human 
patients. Based on data from crushes in frf fish, we predicted that main focus should be 
given to callus formation and ossification in OI patients. We found out that in frf 
inflammation is not affected, therefore focus should not be given to this stage. Callus 
formation was perturbed as shown through our crush model, which can be nicely 
explained, as frf mutation is known. Due to effect which mutation in bmp1 has on collagen 
fibres, here presented results falls in place. However, in the case of mutation in gene of not 
known function, zebrafish model can be useful in helping to determine if mutation is 
correlated with bone problems, and determining which fracture recovery stage is affected. 
That knowledge could help to direct patient treatment to the specific fracture recovery 
stage in case of fracture occurrence. Preventative treatment could also be implemented or 







3. Chapter 3 – Bisphosphonates 
affect crush remodelling 
3.1. Introduction 
3.1.1. Bisphosphonates overview 
Bisphosphonates, the analogues of pyrophosphates with a carbon instead of an oxygen 
bridge between two phosphates (fig 3.0A), were already known to scientists in 19th 
century (Rodan and Fleisch, 1996). After being used in industry as anticorrosive and 
antiscaling agents, researchers found a use for them in the treatment of bone diseases. 
Due to their calcium chelating properties they express high affinity to bone matrix and 
influence bone resorption by triggering osteoclast apoptosis (Hughes et al., 1995). In 
addition, they are shown to prevent osteoblast and osteocyte apoptosis, which was used to 
treat diseases characterized by low bone density (Plotkin et al., 1999).  
 




A chemical structure comparison between pyrophosphate and bisphosphonate 
B chemical structures of examples of non-nitrogenous bisphosphonates 
C chemical structures of examples of nitrogenous bisphosphonates 
(Drake et al., 2008) 
 
3.1.2. Types of bisphosphonates 
There are two types of bisphosphonates, non-nitrogenous (fig 3.0B) and nitrogenous (fig 
3.0C), possessing different properties and performing different mechanisms of osteoclast 
inactivation. Non-nitrogenous bisphosphonates, such as Etidronate or Clodronate, are 
metabolized in the cells to non-hydrolyzable analogs of ATP, competing with endogenous 
ATP and inducing osteoclast apoptosis (Frith et al., 1997). Nitrogenous bisphosphonates, 
such as Pamidronate, Alendronate or Zoledronate, act by blocking farnesyl diphosphate 
synthase (FPPS) metabolism, thus affecting mevalonate pathway. Blocking FPPS prevents 
the formation of farnesol and geranylgeraniol, important for sub-cellular trafficking, 
resulting in a disruption of osteoclasts cytoskeleton (van Beek et al., 2003). Nitrogenous 
bisphosphonates possess much higher bone affinity that non-nitrogenous ones, and result 
in the lesser side effect, thus they are more commonly used as pharmaceutics (van Beek et 
al., 2003).  
3.1.3. Bisphosphonates in clinic 
Bisphosphonates became an established treatment for patients with bone disorders like 
osteoporosis, Paget's disease or Osteogenesis Imperfecta (OI). It was shown that daily 
alendronate treatment significantly improved the quality of life in children with OI, based 
on markers such as self-care (WeeFIM), mobility (PEDI), well-being, and use of analgesic 
scores (Seikaly et al., 2005). Clinical studies on OI patients report the reduction in 
spontaneous fractures, decreased bone pain, improved energy, and increased ambulation 
upon bisphosphonates treatment (Cho et al., 2014). However, negative effects such as 
gains in bone thickness, prolonged time to heal osteotomies, decrease in the rate of bone 
remodelling due to problems with callus resolving caused by inefficient osteoclast work 
were also reported (Anam et al., 2015).  
3.1.4. Bisphosphonate treatment reduce spontaneous 
bone fractures formation 
Alendronate, a type of nitrogenous bisphosphonates, was shown to reduce the possibility 
of spontaneous fractures (Anam et al., 2015). In case studies, alendronate treated OI 
infants showed improvement of bone density and fracture reduction (Akcay et al., 2008). 
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Bisphosphonates were shown to increase bone density (Schindeler et al., 2008), yet 
decrease the healing rate of the osteotomy (Munns et al., 2004). Effect of bisphosphonates 
on repair of bone fractures remains unclear (Munns et al., 2004). 
3.1.5. Long term effect of bisphosphonate treatment 
Although data suggest overall positive effect of bisphosphonates on young OI patients, 
effects of prolonged treatment from infant stage are unclear (Anam et al., 2015). Medics 
express concerns including off-target effects, overall changes to bone density and bone 
strength, changes in OI bone matrix composition, effects on different type of bones, and 
effect of treatment on different OI types (Akcay et al., 2008). To address these and other 
questions an efficient OI models, which respond to bisphosphonate treatment, is needed.  
3.1.6. Animal models used in assessing effect of 
bisphosphonate treatment on fracture healing 
Influence of bisphosphonate treatment on fracture healing has been assessed in several 
model organisms (Savaridas et al., 2013) including dogs (Lenehan et al., 1985), mice (Burns 
and Corwin, 2013) and rats (Hodgkinson and Dzau, 2015). Results of animal studies show 
that bisphosphonates possess an inhibitory effect on fracture healing by slowing down 
remodelling process in wild type animals (Lenehan et al., 1985, Savaridas et al., 2013), yet 
showed no significant effect on Brtl/+, murine OI model (Burns and Corwin, 2013). Studies 
on rats showed that bisphosphonates reduce repair of bone micro damage and that there 
is a need of drug washout period, such as ‘drug holiday’, in long term bisphosphonate 
treatment (Hodgkinson and Dzau, 2015). 
3.1.7. Alendronate treatment in fish 
It has been previously reported that bisphosphonate treatment can reduce osteoclasts 
activity in teleost larvae (Yu et al., 2016). In a medaka osteoporosis model, it was shown 
that alendronate can reduce activity of ectopically recruited osteoclasts (Yu et al., 2016). 
3.1.8. Aim of experiments shown in this chapter 
The aim of this chapter is to assess if alendronate treatment in a zebrafish OI model 
reduces spontaneous fracture formation and to determine the influence of alendronate on 




3.2. Materials and methods 
3.2.1. Bisphosphonate zebrafish treatment  
Alendronate sodium trihydrate (Sigma A4978) was dissolved in fish medium at 
concentrations from 25 to 500µg/ml. Fish were drug treated by immersion in the drug 
solution for 3h per treatment session.  
For recovery, fish were returned to a tank of fresh water.  
3.2.2. Treated fish husbandry 
Treated fish were kept in separate tanks, under standard husbandry conditions, with 
feeding and water changes performed as normal. 
3.3. Results 
3.3.1. Juvenile OI zebrafish respond to alendronate 
treatment  
I decided to treat OI zebrafish model, frf mutant, with clinically relevant bisphosphonates, 
aiming to reduce the amount of spontaneous fracture occurrence through late stages of 
metamorphosis. I followed a ‘drug holiday’ treatment regime (Diab and Watts, 2013), 
where patients were treated for a certain period of time allowing drug accumulation in the 
body followed by a break in treatment. Due to strong drug affinity to the bone, alendronate 
was shown to persist in human bone for up to 10 years after treatment (Diab and Watts, 
2013). 
Two groups of frftm317 zebrafish, 7 individuals in each, were checked for spontaneous 
fractures at 6wpf. At that stage no spontaneous fractures were observed (fig 3.1C), 
therefore any observed fracture reported at later time points occurred after the start of the 
treatment. To ensure a fair comparison between the two groups, similarly sized fish were 
paired and distributed one into each group. In order to mimic clinical practice, juvenile OI 
zebrafish frftm317 were subjected to repetitive, pulsed alendronate treatment, mimicking 
‘drug holiday’ treatment style. Treatment started at 6wpf and lasted for 3 weeks. Twice a 
week (on Tuesdays and Fridays) fish were moved to drug or mock solution for 3h each day 
(3pm to 6pm) (fig 3.1A). One group was subjected to 50 µg/ml alendronate treatment, 
second to mock treatment. The mock treatment included moving fish between tanks, but 
there was no drug addition to their water. After treatment, fish were returned into fresh 
tank water. Fish were imaged at 6wpf, 11wpf and 13wpf (fig 3.1C, D). 
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Reduction in the number of spontaneous fractures in alendronate treated fish was 
observed (fig 3.1B). The difference in spontaneous fracture occurrence between treated 
and mock treated fish groups was significant at 11wpf (2weeks post treatment), where 
treated fish showed significant reduction of fractures as compared to mock treated fish. 
Significance was calculated using Mann-Whitney statistical test. By 13wpf both groups 
presented with spontaneous fractures in the fins, however, there appeared to be a lower 
number of fractures in treated fish. This difference in fractures between the groups at 
13wpc was not significant (fig 3.1B). There was a large variation in fracture numbers 
indicating a stochastic process. While imaging drug and mock treated fish, I also imaged frf 
fish from the same batch which were not moved to treatment tanks. This was to control for 
fractures caused by repeated handling. These frf fish showed a similar rate of tail fractures, 
indicating they occur due to the genetic lesion (fig 3.1D). Thus, the significantly lowered 
amount of fractures in treated fish is an effect of drug treatment. Therefore, I concluded 
that there is a trend in fracture reduction in OI fish model following alendronate treatment, 
however, better treatment dose or higher n-number would be needed to further 
substantiate long term alendronate effect on spontaneous fracture reduction in juvenile OI 
zebrafish. 
 
Figure 3.1 Alendronate treatment reduces amount of spontaneous fractures in juvenile 
OI zebrafish 
A) graphical representation of alendronate ‘holiday treatment’ on juvenile fish. Fish were 
treated for 3 weeks (6dpf to 9dpf), twice a week (Tuesday and Friday), 3h each day (3-6pm) 
and imaged on 6, 11 and 13 weeks post fertilization (wpf) 
B) counts of numbers of crushes per tail between two treatment groups (0 and 50µg/ml). 
The Difference between those 2 groups was tested by Mann-Whitney statistical test and 
showed a significant difference at 11wpf but not at 13wpf, n=7 
C) difference in overall appearance of frf mutant and wild type fish at 6wpf. Enlarged panel 
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emphasises abnormal physiology of frf tails showing shortened length, no bifurcations, and 
lack of spontaneous fractures at this stage 
D) spontaneous fractures formation by 11wpf and reduction in their amount at 
Alendronate treatment. Yellow circles indicate spontaneous fractures. 
Scale bars corresponds to 1mm in panels in C, and 300µm in all panels in B 
 
3.3.2. Alendronate affects bone fracture healing in wild 
type fish 
Different effects of alendronate treatment for fracture healing have been reported in 
several model animals (Savaridas et al., 2013, Xue et al., 2014, Lenehan et al., 1985). As I 
have shown that alendronate reduces spontaneous fracture rate in juvenile frftm317 fish, I 
decided to determine alendronate ability to influence bone fracture recovery. A number of 
treatment regimes and range of concentrations (0, 25, 50, 75, 100, 250, 500µg/ml) were 
tested on wild type fish to optimise the conditions. In the first scenario, fish were treated 
with a range of concentrations (0 - 500µg/ml) for 24 hours before the crush (hbc), then, 
crush injury was introduced, followed by returning fish into treatment solution for another 
24h, (48h continued treatment) (fig 3.2A). 1dpc fish were examined for abnormalities. At 
4dpc fish were stained with calcein and imaged in order to assess if initiation of callus 
mineralisation was taking place in alendronate treated fish (fig 3.2E). 
 
Figure 3.2 Negative effects of continuous alendronate treatment on fracture healing 
A) graphical representation of the experimental set up for determining the optimal 
alendronate concentration for treatment of adult fish: 1 day of drug treatment, followed by 
crush injury and returning fish to drug solution for another day. Fish were imaged on 1dpc 
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and on 4dpc following calcein staining. Colour solutions indicate fish submersion in a drug 
or calcein. 
B) percentage of rays which have lost distal part of fractured ray evaluated 1dpc  
C, D) defects observed in rays of fish treated with high alendronate concentration 1dpc (C) 
and 7dpc (D). Red arrows indicate loss of ray distal to the crush, purple arrow indicates 
single ray segment loss, yellow arrows indicate misplacement of broken ray placed in 
between two fractured rays, brown arrow indicates non-healing skin wound 
E) 4dpc calcining stained fractured rays at the range of fish treated with alendronate, 
showing initiation of callus ossification at 0, 25 , 50 and 100µg/ml and a lack of 
regeneration in 250 and 500µg/ml  
Scale bar corresponds to 50µm in all panels 
 
3.3.2.1. Prolonged exposure to high levels of alendronate leads to a 
loss of distal ray following fracture  
At the highest concentrations (250 and 500µg/ml), ray segments distal to the fracture site 
were lost, including the segments that were crushed (red arrows, fig3.2). 12.5% of 
fractured rays lost their distal part at 100µg/ml, almost 90% at 250µg/ml, while at 
500µg/ml all fractured rays were lost, sometimes (20% of them) together with adjacent, 
unfractured rays (fig 3.2B, images not shown). There were also cases where only the 
fractured segment was lost, creating a hole in the tail (purple arrow, fig 3.2C). In other 
cases, rays adjacent to the fractured ones were affected, showing breakages and 
misplacements (yellow arrows fig 3.2D). Moreover, regeneration of lost rays was never 
observed, even at 21dpc. Loss of adjacent rays at the highest concentrations, as well as 
non-healing skin wounds (brown arrow fig 3.2D) suggested the broader effect of treatment 
beyond the reduction of osteoclast activity. Hence the range was limited to only 25-
100µg/ml alendronate for subsequent experiments. 
3.3.3. Alendronate treatment does not block callus 
formation but affects callus resorption 
I performed a new set of experiments with alendronate range restricted to a maximum of 
100µg/ml (fig 3.3). I varied not only the drug concentration, but also the length of 
treatment. I tested continuous 48h treatment with crush introduced in the middle of the 
treatment (fig 3.3B), in addition to two types of pulse treatments: short pulse treatment 
(4hbc) and long pulse treatment (14hbc) (fig 3.3D). In order to assess temporal changes in 
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callus formation, we alternated bone staining with calcining and Alizarin Red S (fig 3.3B and 
D), which allowed me to assess progressively deposited nascent bone (fig 3.3A and E).  
3.3.3.1. Continuous alendronate treatment affects callus formation 
and resorption 
In continuous treatment, callus formation in fish treated with 25µg/ml alendronate appears 
normal and follows the rates observed in mock treated fish callus formation rate (fig 3.3A, 
C). In contrast, the 100µg/ml treated group shows significant reduction in the hard callus 
formation stage (5dpc to 11dpc). However, both treated groups show continuous increase 
in callus size up to 56dpc, while the non-treated fish data shows reduction in callus size 
indicating remodelling stage consistent with previous observations (fig 3.3A, C). This data 
suggests that continuous alendronate treatment affects mineralised callus formation at 
higher drug doses and also disrupts bone remodelling at both high as well as low drug dose.  
3.3.3.2. Pulse alendronate treatment affects callus resorption 
In both short and long pulse treatments, whilst callus formation appeared unaffected, 
significant differences in a callus size were observed between mock and drug treated fish 
from 21dpc onwards (fig 3.3F and G), hence in the time frame normally allocated for callus 
remodelling (based on the results presented in chapter 1). I observed continuous increase 
in callus size in the treated fish and the normal decrease in callus size was not observed at 
all up to at least 56dpc. We observed no qualitative difference in response to treatment 




Figure 3.3 Temporal formation of mineralised callus after crush injury in alendronate 
treated adult, wild type zebrafish  
A) temporal progression of mineralised callus formation in continuously treated fish, yellow 
arrow indicates bone debris  
B) graphical representation of continuous treatment experimental set up. Colour of 
solutions indicate either drug, calcein or Alizarin Red S 
C) callus size measurements from fish continuously alendronate treated, showing 
significantly smaller callus in the callus formation stages in high alendronate concentration 
and lack of callus size reduction in both drug treated groups. ** p<0.01, **** p<0.0001, 
ANOVA, Tukey's multiple comparisons test, n=8 
D) graphical representation of pulse treatment experimental set up. Colour of solutions 
indicate either drug, calcein or Alizarin Red S 
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E) temporal progression of mineralised callus formation in pulse treated fish  
F) callus size measurements from fish treated with the long pulse of alendronate prior to 
the crush showing significant difference in callus size through remodelling stage between 
alendronate treated and mock treated fish. * p<0.05, ** p<0.01, *** p<0.001, **** 
p<0.0001, ANOVA, Tukey's multiple comparisons test, n=8 
G) callus size measurements from fish treated with short pulse of alendronate prior to the 
crush showing the significant difference in callus size through remodelling stage between 
alendronate treated and mock treated fish * p<0.05,  ** p<0.01, *** p<0.001 
Scale bar corresponds to 50µm in all panels in A and E 
3.3.4. Alendronate treatment reduces initial osteoclast 
activity   
I observed that upon continuous alendronate treatment, bony callus was formed normally, 
however unlike the mock treated fish, drug treated fish tails retained bony debris and sharp 
edges of bone (yellow arrows in fig 3.3A and 3.4A), suggesting reduced osteoclast activity. I 
examined clearance of bone debris and sharp edges following continuous alendronate 
treatment in 0, 25, 100µg/ml. Results showed the prolonged persistence of bony debris 
and sharp bone edges in drug treated animals (fig 3.4C). 
 




A) temporal progression of clearance of bone debris and sharp edges, yellow arrow 
indicates sharp edges/ bone debris. Scale bar corresponds to 50µm in all panels 
B) graphical representation of continuous treatment experimental set up. Colour of 
solutions indicate either drug, calcein or Alizarin Red S   
C) temporal progression in sharp edges removal, n=8 
 
3.3.4.1. Alendronate treatment does not block osteoclast 
recruitment  
Results reported in fig 3.3 and fig 3.4, showed no reduction in callus size, yet impaired 
debris clearing in individuals exposed to continuous alendronate treatment. This suggested 
a lack of or reduced osteoclast activity, therefore I decided to examine osteoclast 
recruitment to the crush site. I performed continuous treatment in the initial range 
between 25µg/ml and 500µg/ml, as well as short and long pulse experiments in drug 
concentration range 25µg/ml and 100µg/ml. Tails were collected 1dpc and the whole 
mount in situ hybridization of ctsK was performed on them in order to check osteoclasts 
presence. Osteoclasts were detected at all concentrations in all types of treatment (fig 3.5), 
indicating that alendronate does not affect osteoclasts recruitment to crush site. Therefore, 
I concluded that alendronate might have an effect on osteoclast performance (fig 3.3), but 





Figure 3.5 Alendronate treatment does not affect osteoclast recruitment to the crush 
site 
Whole mount in situ hybridization for ctsK has been performed on zebrafish tails after 
continues, short pulse and long pulse treatment. Osteoclast were recruited to all crush sites 
despite the drug treatment.  
Scale bar corresponds to 50µm in all panels 
3.3.5. Alendronate does not have significant effect on 
callus size in OI fish  
After optimising treatment conditions on wild type fish, I performed crushes on 
alendronate treated frf fish in order to model what effect alendronate treatment might 
have on fractures of alendronate treated OI patients. I introduced crushes to 3 months old 
(3mpf) frf fish, which were ‘drug holiday’ treated at 6wpf (fig 3.6A, B) and their untreated 
peers which were treated with long pulse of alendronate prior to the crush (fig 3.6 D, E). 
Callus size was measured at 7, 11 and 21dpc for ‘drug holiday’ treated and 5, 10 and 24dpc 
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for long pulse treated fish. Consecutive staining with Calcein and Alizarin Red S were 
applied as per previous experiments in order to track bone deposition at the crush site. The 
results show no significant difference in callus size between drug treated and mock treated 
frf fish (fig 3.6). Neither ‘drug holiday’ nor long pulse treatment had a strong effect on 
callus size in frf fish. However, in alendronate treated fish, I observed persistent bone 
debris on which new bone matrix was deposited (yellow arrows in fig 3.6), indicating 
inefficient osteoclast activity, but efficient deposition by osteoblasts.  
 
Figure 3.6 Alendronate treatment has no significant effect on mineralized callus in frf fish 
A) temporal progression of mineralised callus formation in frf fish after ‘drug holiday’ 
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alendronate treatment, yellow arrows indicate unremoved bony debris on which 
mineralisation get deposited 
B) graphical representation of experimental set up where colour of solutions indicate drug, 
calcein or Alizarin Red S 
C) callus size measurements from 3mpf frf fish, which were ‘alendronate holiday’ treated 
prior to the crush. No significant difference in callus size between alendronate treated and 
mock treated fish can be detected, n=8 
D) temporal progression of mineralised callus formation in frf fish after long pulse 
alendronate treatment 
E) graphical representation of experimental set up where colour of solutions indicate drug, 
calcein or Alizarin Red S 
F) callus size measurements from 3mpf frf fish, which were treated with long pulse of 
alendronate prior to the crush showing no significant difference in callus size between 
alendronate treated and mock treated fish 
Scale bar corresponds to 50µm in all panels in A and D 
3.4. Discussion 
3.4.1. Spontaneous fracture formation in juvenile 
zebrafish as a model for OI drug testing 
OI zebrafish model, frf mutant, treated with alendronate at late stages of metamorphosis, 
showed to be responsive to bisphosphonate treatment. These results were comparable to 
results obtained from rodent models (McCarthy et al., 2002). The data presented in here 
show that alendronate treatment in zebrafish OI model reduces spontaneous fractures in 
juvenile fish following ‘drug holiday’ alendronate treatment. Reduction in spontaneous 
fractures formation resembles human patients’ responses to alendronate treatment 
(Seikaly et al., 2005), therefore we propose OI zebrafish as an accurate model for potential 
OI drug testing. 
3.4.2. High alendronate concentration is strongly 
disruptive for fracture healing 
Disruptive effects of high dosage of prolonged bisphosphonate treatment in orthopaedics 
patients were raised as problems by clinicians and were researched on by scientists 
working on animal models (Hodgkinson and Dzau, 2015). In here, I showed that 
alendronate had a strong, disruptive effect on zebrafish crush healing. Prolonged exposure 
of high alendronate concentration treatments led to ray loss and spontaneous loss of 
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uncrushed rays. Bisphosphonates are known for potent calcium chelating properties, which 
targets them to bone efficiently (Hughes et al., 1995), but upon over exposure 
bisphosphonates may reduce available calcium in the tissue. I predict that in my 
experiment, high alendronate concentration caused a major shift in ion balance in the 
tissue. Thus off target effects on wound healing and tissue integrity may have resulted. 
These results bring to the focus optimization of bisphosphonate doses and treatment 
times, as well as a need for developing a technique allowing bisphosphonate removal from 
the bone upon overexposure. Chemical trials are already performed in rodents 
(Hodgkinson and Dzau, 2015), therefore we propose zebrafish crush model as an 
appropriate and cheaper alternative animal model. 
3.4.3. Efficient drug to bone binding occurs after as little 
as 4h of treatment 
Due to variability of experimental regimes presented in this chapter, with altered length of 
alendronate treatments due to drug dosage optimizations, I was able to assess the speed of 
drug to bone affinity. Results from the short pulse treatment followed closely the results 
seen after long pulse treatment, indicating that fish drug absorption from the water is fast, 
and that the drug affinity to fish bones is high. It appeared that 4h of pre-crush alendronate 
treatment was sufficient to give as strong results as long pulse treatment. Moreover, 
following previous results from continuous treatment, where I saw destructive results on 
induced fractures at high drug doses (250 and 500µg/ml) as soon as 1dpc, suggest that 
absorption and accumulation happen fast and very efficient. 
3.4.4. Alendronate treatment blocks remodelling in wild 
type fish  
According to the data presented in this chapter, alendronate had a negative effect on 
mineralized callus remodelling. No sign of remodelling in crush healing of alendronate 
treated fish was observed. Mineralised calluses were formed as normal, however, no 
reduction was observed in their size in time, as it was the case for untreated fish. This 
serves as a strong indicator that in alendronate treated fish osteoclasts do not perform 
their role correctly and they do not reduce the size of the callus. These results are 
comparable to results obtained from rodent bone fracture experiment, where lack of callus 




3.4.5. Reduced initial osteoclast activity results in 
decreased bone debris clearance 
I have observed that in drug treated crushes bony debris and sharp bone edges formed at 
the crush initiation were not cleared away at the normal rate. Clearance took longer that in 
untreated controls and was dose dependent. Lack of bone debris resorption can be 
explained, as above, by reduced osteoclast activity. It could also contribute to the overall 
increase in callus size in treated fish, as nascent bone would be laid around the sharp edges 
encapsulating scattered bone debris.  
3.4.6. Alendronate does not block osteoclast 
recruitment to the crush site 
On the other hand, my data showed that osteoclasts were normally recruited to the crush 
site, despite the strength or timing of alendronate treatment. Based on these results, I 
conclude that alendronate treatment affects osteoclasts activity, but does not interfere 
with the mechanism which recruits osteoclasts to the crush site. This data is consistent with 
medaka research data (Yu et al., 2016). Moreover, based on ISH results, osteoclasts’ 
clumping was suspected, similar to previously described (Yu et al., 2016). However, to 
confirm this statement more investigation is needed, for example measurements of 
osteoclast size would be required. 
3.4.7. Alendronate treatment does not seem to affect 
fracture healing of OI fish   
Data presented in this chapter showed that alendronate had no effect on fracture healing 
in frf fish, in neither ‘holiday treated nor long pulse treated experimental regimes. These 
results were comparable to results obtained from mice OI model, Brtl/+ mice (Burns and 
Corwin, 2013), reporting that upon alendronate treated wild type mice showed alterations 
in the healing dynamics and lack of callus remodelling, while Brtl/+ showed no significant 
differences in fracture healing upon treatment (Burns and Corwin, 2013). 
I predict that lack of strong evidence of reduction of osteoclast activity in alendronate 
treated frf arises from initial low osteoclast activity in callus remodelling in those mutants. 
As described in the previous chapter, osteoclast driven remodelling stage in frf fish is hardly 
distinguishable. Fish struggle to re-build the connection between broken bone parts, 
therefore the importance of restoration of bone structure in the fracture plane, which is a 
main role of remodelling, in these fish loses its priority. Previously, I have shown that in frf 
fish bone anabolic processes overwhelmed fracture healing in frf fish, therefore reducing 
osteoclast activity in them would not give as significant results as in wild type fish.
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4. Chapter 4 – Staphylococcus 
aureus infection of crush injury 
4.1. Introduction 
4.1.1. Staphylococcus aureus as an infection cause 
Staphylococcus aureus (S. aureus) is a gram positive bacterium commonly found on human 
skin and within the respiratory system, with almost 50% of human population being 
colonized (Frank et al., 2010). This normally non-pathogenic commensal bacterium can be a 
cause of serious infections when invading open wounds or entering the blood stream 
causing bacteraemia (Tong et al., 2015). Many of the S. aureus cases were reported in 
strongly industrialized countries and they are highly associated with the use of surgical 
implants (Tong et al., 2015). Historically, S. aureus infections were successfully treated with 
penicillin, however, the incident rise of antibiotic resistant strains, such us Methicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate S. aureus (VRSA), 
caused emerging problems in clinics (Chambers and Deleo, 2009). Bacteria are usually 
passed from human to human (Yang et al., 2012). S. aureus is known as being highly 
resistant to environmental factors so it can non-pathogenically colonize human skin and 
reside there before infecting the host. It can also be transmitted on objects, such as 
medical tools or implants, and through the air, bringing an issue of cross-infection in the 
hospitals (Yang et al., 2012). The broad range of diseases caused by S. aureus, and difficulty 
in killing this infectious bacterium brought S. aureus to the focus of epidemiologists and 
resulted in it being classified as a serious, complex clinical problem (Tong et al., 2015). The 
range of infections caused by S. aureus include bacteraemia, infective endocarditis, 
pleuropulmonary infections, skin and soft tissue infections, prosthetic devices infections 
and osteoarticular infections (Tong et al., 2015), but for the purpose of this study I focus 
here mainly on the latter.  
4.1.2. Bone related S. aureus infections 
S. aureus is the major pathogen of bone fractures. S. aureus osteoarticular infections can 
be divided into three main classes: osteomyelitis (bone infection), prosthetic joint infection, 
and native joint septic arthritis (Tong et al., 2015). Osteomyelitis is characterized by bone 
infection, destruction, and re-formation, and is divided into haematogenous (caused by 
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infected blood) and contiguous (caused by contact with an infected object e.g. tissue or 
implant) (Waldvogel et al., 1970). Based on experiments performed on animal models, it is 
known that osteomyelitis rarely forms in healthy bones, its occurrence requires bone 
infection, trauma or presence of foreign bodies (Lew and Waldvogel, 1997). S. aureus can 
cause bone infection by adhering to bone matrix components such as collagen or laminin 
through adhesion receptors (Elasri et al., 2002). Adhesion helps S. aureus to form biofilms, 
where bacteria hidden from antimicrobial agents can divide, maintaining a constant supply 
of new pathogenic agent, leading to chronic infections (Clauss et al., 2013). Moreover, S. 
aureus can survive internalization in osteoblasts as well as macrophages and upon release 
from dying cells, they can re-infect surrounding tissues (Hamza and Li, 2014). 
4.1.3. Influence of S. aureus infections on bone healing 
Negative effects of S. aureus infections on bone fractures healing, such as delayed 
consolidation, fracture non-union, failed osteosynthesis, the interposition of soft tissue and 
re-fractures are common clinical problems (Kierdorf and Kierdorf, 2011). Bacterial infection 
is one of the most common causes of tibia fracture non-unions (Ciciliot and Schiaffino, 
2010). Several methods were proposed for the early diagnosis of bone fracture infection 
(Bando et al., 2011, Del Debbio et al., 2010). Case studies reported that the posttraumatic 
infection time and the time of infection detection are crucial in determining infection 
strength and effect that infection has on healing process (Arthur and Heber-Katz, 2011), 
therefore clinicians report the need for further research this matter. Due to lack of 
possibility to research on patients, animal models are needed. 
4.1.4. Animals used in S. aureus related bone infections 
Scientists introduced controlled bone infections in animals in order to understand the 
mechanisms driving infection and its subsequent impact on bone repair. Several animal 
models, such as rabbits (Henriksson and Brisby, 2013), rats (Murray et al., 2012) or mice 
(Koriyama et al., 2012) were used in the research on fracture infection. Diverse ways of 
introducing pathogen to the host bone were developed, including direct S. aureus 
injections to the bone, either through holes drilled in bones (Henriksson and Brisby, 2013) 
or through introduced bone fractures (Murray et al., 2012). Another infection techniques 
involved usage of S. aureus colonialized medical devices and implants, such as joint 
replacements (Koriyama et al., 2012). The diversity of surgical procedures and ways of 
bacteria inoculation was developed in order to model as many clinical scenarios observed 
in patients as possible.  
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4.1.5. Zebrafish in S. aureus studies 
Danio rerio (embryo and larvae stage) was used in studies on host-pathogen interactions, 
virulence, and pathogenicity during S. aureus infections, showing possibility of zebrafish 
infection with non-host specialized pathogen (Prajsnar et al., 2008), however publications 
about S. aureus skeleton infections in adult zebrafish nor any adult teleost fish were not 
found. 
4.1.6. Aim of experiments presented in this chapter 
Up to date, model of bone infection in zebrafish has not been produced. The aim of this 
chapter is to show the possibility of localized infection in the tail of adult zebrafish, and the 
establishment of the method of S.aureus infection into zebrafish ray crush. Upon obtaining 
successful infection, the second aim is to characterize S.aureus pathogenic behaviour, as 
well as examine the influence of infection on the crush healing. 
4.2. Material and methods 
4.2.1. S. aureus strains used 
Staphylococcus aureus SH1000 derived strains, mCherry-expressing and GFP-expressing 
(Prajsnar et al., 2008), were kindly provided by Josie Gibson from the Steve Renshaw 
laboratory.  
4.2.2. S. aureus preparation 
The overnight culture was set up from single colony spread on an agar LB plate with 
10µl/ml tetracycline. 25ml of LB with antibiotic was inoculated and incubated at 37˚C with 
shaking overnight. After 16-18h of incubation, 500µl of the culture was transferred to a 
fresh 50ml tetracycline LB and grown at 37˚C in a shaker for 2h. OD of culture was 
measured and bacteria were spun down (13 min, 21 000rpm, 4˚C), and re-suspended in 
PBS, which amount was calculated by C1*V1 = C2*V2 equation (where C1 – measured 
concentration, V1 - volume spun down, C2 - required concentration, V2 – volume of PBS to 
re-suspend bacteria). Re-suspended bacteria were kept on ice, ready for immediate use for 
injections. 
4.2.3. S. aureus injections 
Bacteria were injected into the crush site at a range of time points after the crush 
(immediately post crush (0hpc), 0.5dpc, 1dpc, 2dpc). Glass needles used for injections were 
pulled with Sutter Instruments P-97 Flaming/Brown Micropipette Puller using Standard 
Wall Borosilicate Tubing without Filament (Sutter Instruments B100-50-10). Fish were 
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anaesthetised in 0.13% tricaine, rays in the tail were crushed (method described in chapter 
1), and bacteria were injected into the tail through the crush in the bone using Narishige 
IM-300 Microinjector. The needle was inserted through the crush inside the ray into the 
intra-ray space proximal to the breakage. Bacteria were injected while retrieving the needle 
from the crush. After infection, fish were returned to separate tanks filled with standard 
tank water. 
4.2.4. Control injections 
0.005% calcein was injected as a control. 
4.2.5. Infected fish husbandry 
Infected fish were kept separately in a designated rack. They were fed as normally, while 
water in the tanks was changed daily to avoid the bacterial outbreak in the water. 
4.3. Results 
Diverse methods of controlled, S. aureus open fracture infections, such as direct bacterial 
injection into the fracture site or injection cutaneous injection in the fracture proximity, 
were performed on rodent research animals models (Reizner et al., 2014), however, 
examples of localized bone infections in adult zebrafish were not found. Adapting and 
optimizing the method was a challenge. I have decided to perform direct bacterial 
injections into the crush site. This technique gives control over the infection source, directs 
the outbreak, allows tracking the bacterial movement and limits initial randomness of 
infection opportunity, in contrast to immersing wounded fish into fish water infected with 
bacteria.  
4.3.1. Zebrafish clear small localized infection in 3 days. 
Bacterial injection method was adapted from (Prajsnar et al., 2008). Bacteria were injected 
into the crush at a concentration of 2500 cfu/nl which, based on (Prajsnar et al., 2008) is 
optimal for injections of S. aureus into zebrafish embryo cardiovascular system. 




Figure 4.1 Small, localized to crush S. aureus infection are cleared in 3 days  
A) injection efficiency and accuracy was tested with fluorescent calcein and green 
fluorescent S. aureus 
B) time course of infected crush, which allowed tracking the clearance of bacteria from the 
crush site. Both spatial and temporal distribution of bacteria can be assessed, as well as 
progression in the crush healing 
C) graph representation of pooled results of bacteria clearance from 20 infected crushes, 
showing progressive bacteria clearance up for to 3 days, when all crushes were cleared 
from infection. Initial efficiency of injections can be examined based on readouts form 1hpc 
D) graph representation of ray loss influenced by injections in S. aureus infected crushes as 
well as calcein injected controls, showing that crush injections cause high disturbance to 
the broken rays  
E) images representing recovery after the injury, showing the difference in the rate as well 
as the quality of regrown rays, between infected and control fish. Nascent bone was 
stained with calcein. Yellow arrow indicates kinked ray forming following S. aureus 
infection, pink arrow indicates spontaneous fracture 




While fluorescent calcein was gone from the crush 2 days post infection (dpi), bacteria 
clearance took zebrafish up to 3 days to clear (Fig 4.1B). Injected bacteria (0.5nl) initially 
resided within the hemiray cavities of proximal and distal parts of broken ray, with slight 
spillage into intradermal space, and at this point bacteria appeared as a strongly 
fluorescent mass, where individual bacteria were not distinguishable. By 1dpi colonies were 
observed. Excess injection fluid was slowly reduced over 24hr, improving image clarity. By 
2dpi, a reduction in the number of bacterial colonies was noticed and by 3dpi all had been 
cleared away (Fig 4.1B). At 1hpc, 75% of injected crushes had visible bacteria (Fig 4.1C), I 
imaged injected crushes over 3days (Fig 4.1B, C). Despite relatively fast bacterial clearance, 
the injection process into the crush appeared to be a generally disruptive procedure as 
almost half of calcein (control) injected crushes, and 65% of S. aureus injected crushes lost 
distal part of the ray (Fig 4.1D). For calcein injections, lost rays are restored by little 
blastema formation and regeneration (control, Fig 4.1E). However, in infected crushes, 
infection visibly influenced regrowth of lost rays making them kinked and distorted (yellow 
arrow in Fig 4.1E). It also led to the formation of spontaneous crushes in the rays adjacent 
to the ones possessing infected crushes (pink arrow in Fig 4.1E) and occasionally to loss of 
whole adjacent rays. 
4.3.2. Large volume injections into crush site lead to the 
further loss of the distal part of a broken ray 
An initial experiment showed that small localized infections were cleared by 3dpi (fig 4.1 C). 
Since the aim was to achieve a prolonged S. aureus bone infection, I have decided to 
increase the volume of injected bacteria, keeping concentration at the same level of 2500 




Figure 4.2 Large volume S. aureus injections into the crush site lead to the loss of the 
distal part of a fractured ray, prolonged time of bacterial infection, and increased fish 
mortality  
A) spatial and temporal distribution of fluorescent red S. aureus in the zebrafish tail after 
high volume bacterial injections into crushed rays. High volume injections lead to a loss of 
all parts of the crushed rays and persistent bacteria presence blocked regeneration of lost 
rays. White arrows indicate persistent bacteria at 7dpi, blue arrow indicates the lack of 
regrowth. 
B) re-growing rays showed impaired formation due to bacteria presence when checked 7 
days after injury. White arrows indicate persistent bacteria, blue arrows indicate lack of 
regrowth, yellow arrow indicates newly formed outgrowing ray, invading a present non-lost 
ray  
C) 2 and 3 weeks post injury recovery impairment was clearly visible due to previous 
bacteria presence. While control fish fully restored their lost ray fragments, previously 
infected fish showed strong malformations of re-growing rays as well as loss of adjacent to 
crushed rays and inability to regrow them  
D) graphical representation of tail, where red rectangular shows area imaged in panel A  
E) graph representation of ray loss influenced by high volume injections showing increased 
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to 72% ray loss in crushes injected with a high volume of bacteria solution 
F) graph representation of bacteria clearance rate from crushes infected with high volume 
of S. aureus showing that even 7dpi around 30% of crushes still showed presence of 
bacteria 
G) Kaplan-Meier curve of infected fish along days post infection (dpi) showing that half of 
infected fish died as soon as 4dpi 
Scale bars corresponds to 100µm in all panels in A and B, and 300µm in panels in C 
 
Following experiments were performed with S. aureus expressing mCherry, in order to 
distinguish it from green fluorescence of calcein staining. Increased injection volume 
induced more ray loss than previously described, increasing ray loss rate up to 72% (fig 
4.2E) from 65% reported after small volume bacterial injections (fig 4.1D). The loss was 
observed as soon as 1hpi indicating that rays were lost due to the mechanical disturbance 
by injected volume rather than a result of bacterial infection. I observed that injected fluid 
spilled into the inter-ray spaces filling intradermal space with S. aureus injection fluid (fig 
4.2A). The high amount of mCherry positive bacteria can be observed in the infected 
crushed tails (fig 4.2A). As soon as 1dpi bacteria form bigger clumps, indicating bacterial 
growth and colonies formation. Bacteria were slowly cleared, but even 7 days post 
infection I were able to detect bacteria in the tail (white arrows, fig 4.2A, B). Regeneration 
of lost rays was blocked (blue arrow, fig 4.2A). By 7dpi S. aureus was still present in 30% of 
infected crushes (fig 4.2F). Interestingly, for lost rays, regrowth did not initiate until 
bacteria were cleared. Normally regrowth can be observed as soon as 3dpc (data presented 
in chapter 1), however, in infected rays regrowth was delayed while the bacteria were 
present. As late as 7dpc no regrowth was observed if bacteria were not cleared (white 
arrows indicates bacteria, blue arrows indicate the lack of regrowth fig 4.2B). In fact, even if 
bacteria where cleared, regrowth was impeded, re-growing rays were kinked and deformed 
or were formed ectopically (yellow arrow fig 4.2B). Abnormal regrowth of lost rays could 
even be seen weeks post infection, with bacteria injected fish being unable to properly 
restore lost rays (fig 4.2C), as compared to control injected rays, which reformed fully. Rays 
adjacent to the infected crushes often showed spontaneous fractures and loss of ray 
fragments. None of the infected crushes fully restored lost rays by 3wpi. In addition, 
injection of large doses of bacteria caused high mortality among infected fish (fig 4.2G), 
although the exact cause of death was not investigated further. It is possible that fish died 
from septic shock caused by bacteraemia. I have visually checked the spread of bacteria to 
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other parts of the fish body, such as gills or mouth, but I did not find any bacterial trace on 
those organs. Necropsy would be required to ascertain the cause of death and systemic 
injection load. 
4.3.3. Crush healing was affected by the concentration of 
injected bacteria, as well as the time of infection. 
Due to the previously observed ray loss, I decided to decrease the volume of bacteria back 
to of 0.5nl (reported in fig. 4.1), and in order to increase the amount of injected bacteria, I 
doubled the concentration of bacteria from 2500 cfu/nl to 5000 cfu/nl. Moreover, based on 
suggestions from orthopaedists who were interested in differences in fracture repair 
progression based on different infection times throughout fracture recovery, I decided to 
infect at 0.5, 1 and 2 days following crushing, checking injection possibilities as well as 
infection progression.  
4.3.4. 1dpc was the most effective while 2dpc the most 
accurate, time points for intra-crush bacterial 
infections.  
Crush injuries were introduced to fish tails 2, 1 and 0.5 days before S. aureus infection. 
Bacteria were injected, providing a range of infections in several stages of early crush 
recovery.  
0.5dpc crush remained as an open tissue. Bacteria injected into this space either dispersed 
or attached to crush periphery only, usually adjacent skin and intra-ray tissue. To 
circumvent this, I inserted the needle into the intra-ray cavity of the adjacent segment and 
injected bacterial liquid there. This led to bacterial accumulation in soft tissue adjacent to 
the crush and not the crushed bone (fig 4.3 A1). When wound closure occurred, bacteria 
infected the crush site by 2dpi (fig 4.3 A2).  
In 1 day old crushes I was able to inject bacteria directly at the crush site, with mild spillage 
to surrounding tissues (fig 4.3 A7). The high number of bacteria was accumulated at the 
crush site showing much higher crush infection efficiency than the 0.5dpc time point 
described above. 
Injections into 2dpc crushes were more challenging. 2dpc crush site was hardened and the 
breakage connection was forming, and there was no free movement between broken ray 
parts. These characteristics made it challenging to penetrate the crush site with a thin glass 
needle. At 2dpi, there was limited free diffusion of injected bacterial solution, therefore 
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bacteria stay tightly packed at the crush plane (fig 4.3 A13). The frequent overflow was 
observed, reducing the amount of bacteria remaining at the crush site.  
4.3.5. Bacteria were excluded from the crush site over 
time 
In all three scenarios, where bacterial injections were performed at different stages of 
crush recovery, bacteria did not remain at the crush site over time. By 3dpi bacteria 
displaced distally for all injection timings (fig 4.3A, C). In order to check if there is a trend of 
bacteria exclusion from the crush site, I examined the temporal and spatial distribution of 
bacteria in reference to the position of the crush (fig 4.3B). The crush images were divided 
according to the scale: 0 indicates crush plane, 1 - end of crushed segment, 2 - middle of 
adjacent segment, 3 – end of adjacent segment. Negative numbers indicated positions 
proximal from the crush, positive numbers indicated positions distal from the crush (fig 
4.3B). I counted the lines which were crossed by a group of bacteria at each time point (red 
lines fig 4.3 B). Results were plotted on the graph, indicating bacterial spatial distribution 
across 5dpi (fig 4.3C). 1dpi data showed that proximity of injection location to the crush 
site was dependent on the stage of crush recovery at the point of injection. By 2dpi, despite 
the initial bacteria position, all bacteria were found approximately the same place, slightly 
beyond the crush plane. At 3dpi almost all of them were seen around the distal edge of 
crushed segment. 0.5dpc and 1dpc injected crushes showed further distal bacterial 
displacement. 2dpc showed the spatial bacterial arrest. The smallest overall displacement 
was seen in the crushes infected 2dpc, while the biggest in the crushes infected 0.5dpc (fig 





Figure 4.3 Time course of bacteria clearance and crush healing in the fractures infected at 
different time points with low volume but high concentration of S. aureus solution 
A 1-6) time course of crush infected with S. aureus 0.5dpc. This panel set up allowed 
tracking spatial and temporal distribution of the green fluorescent bacteria around the 
crush. Results showed that the bacteria were fully displaced from the crush site over time 
A 7-12) time course of crush infected with S. aureus 1dpc, showing that bacteria were also 




A 13-18) time course of crush infected with S. aureus 2dpc  
B) Example images showing how each image was divided order to spatially determine the 
position of bacteria with respect to the position of the crush. Vertical lines divide pictures 
according to the scale: 0 indicates crush plane, 1 - end of crushed segment, 2 - middle of 
adjacent segment, 3 – end of adjacent segment. Negative numbers indicate positions 
proximal from the crush, positive numbers indicate positions distal from the crush. Red 
lines indicate the position of bacteria and the classification selected for that particular 
images. 
C) graph representing spatial and temporal distribution of bacteria in reference to the 
crush plane, showing initial accuracy of injections and bacterial displacement over time 
D 1-3) examples of crushes which did not remove bacteria by 15dpc showing a lack of crush 
repair 
D 1-3) examples of crushes which remove bacteria by 15dpc showing mineralized callus 
formation 
Scale bars correspond to 50µm in all panels 
4.3.6. S. aureus infection blocks crush healing process 
5dpc all infected crushes were stained with Alizarin Red S in order to examine mineralized 
callus formation. In injections performed 0.5 and 1dpc, no bony callus was observed at 
5dpc (fig 4.3 A6, 12), the time point when normally mineralized callus was present 
(previous chapters). Sharp crush edges were still clearly visible (fig 4.3 A6, 12) indicating 
that the crush repair process was not even started. In the group injected 2dpc, slight bonny 
calluses were observed at 5dpc, however, they appeared unchanged from infection date 
indicating arrest of callus growth (fig 4.3 A18). In addition, loose bone debris was noticed as 
along the sharp edges at the crush plane, indicating that crush repair had not occurred. 
4.3.7. Prolonged crush infection blocks crush healing  
All crushes were also checked at 15dpc for callus formation by repeated Alizarin Red S in 
vivo staining (fig 4.3D). At this time point, clear division in the crush healing and bony callus 
formation was observed between crushes which had persistent bacteria present, in 
comparison to those in which bacteria was already cleared away. I was able to observe, 
that in the presence of green fluorescent S. aureus near the crush site, there was no 
evidence of crush healing process in term of mineralized callus formation (fig 4.3 D1, 2, 3). 
Edges still appeared sharp (fig 4.3 D1), loose bony debris were present (fig 4.3 D2) and 
bones were not aligned (fig 4.3 D3). In comparison, crushes from which bacteria were 
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cleared away appeared joined by mineralized calluses on 15dpc (fig 4.3 D4-6). All results 
observed at 15dpc were independent of the timing of the infection in relation to the crush. 
All described outcomes were found in all groups injected either 0.5dpc (fig 4.3 D1,4)., 1dpc 
(fig 4.3 D2,5) and 2dpc (fig 4.3 D3,6). 
4.3.8. S. aureus infection is responsible for prolonged 
crush inflammation 
Prolonged infection appeared to block crush healing. As I saw no signs of hard callus 
formation nor remodelling, I decided to examine the inflammation in infected crushes, by 
infecting crushes in Tg(mpx:GFP) fish. Tg(mpx:GFP) fish possess fluorescently labelled 
neutrophils, therefore I used it as an indicator of inflammation (following the method 
described in chapter 1). S. aureus was injected into the crush site at the peak of crush 
inflammatory response, at 12hpc (based on the results we accumulated and described in 
previous chapters). I took images of GFP positive neutrophils prior to infection (fig 4.4A, 
0.5dpc, ni). Images were taken daily for 5 dpi. At 1dpc I was able to observe bacteria mixed 
with inflammatory cells at the crush sites. By 2dpi bacterial colonies were much more 
distinguishable and accumulation of inflammatory cells at the crush site was clear. 
Prolonged accumulation of both was seen at 3dpi and was slowly fading away on following 
days. Dates of complete bacterial clearance varied between crushes, even between 
different crushes within same individual (fig 4.4A) but all of them followed the trend 
described above. To quantify inflammatory response, I decided to use CTCF calculation 
method (as presented in chapter 2). I calculated total crush fluorescence based on crush 
areas identified by white circles (fig 4.4A). I plotted results of 4.5dpc time course 
graphically and statistically tested differences in CTCF between infected and uninfected 
crushes (fig 4.4B). Data showed the significant increase in total crush fluorescence of 
infected fish at 1.5 and 2.5dpc (1 and 2dpi). Enhanced and prolonged inflammation was 
detected in the S. aureus infected crushes. Big error bars at the graph showing CTCF of 
infected crushes, indicated differences in the rates of progressive bacterial clearance and 
the different strength of inflammatory response at the crush site depending on the spatial 




Figure 4.4 S. aureus infection caused enhanced and prolonged crush inflammation 
A) time series of Tg(mpx:GFP) fish crushes infected with fluorescent red S. aureus 0.5dpc, 
showing the recruitment of fluorescent neutrophils marked by mpx:GFP into the crush site. 
White circles indicate areas which were captures for CTCF measurements; ni – not infected; 
Scale bar corresponds to 100µm in all panels 
B) CTCF results presented on the graph showing significant upregulation in CTCF of infected 
fish on 1.5 and 2.5dpc. Syringe indicates moment of bacterial infection into the crush, *** 
p<0.001, ANOVA, n=8 
4.4. Discussion 
4.4.1. Adult zebrafish are sensitive to S. aureus infection 
In this chapter, I provided an evidence that adult zebrafish, similarly to the zebrafish 
embryos (Prajsnar et al., 2008), are sensitive to S. aureus infections. I showed that bacterial 
infection can be localized at the injury site and can be directly introduced into the crush 
through precise bacterial injections. This accurately mimics human open fracture infection 
conditions (Kierdorf and Kierdorf, 2011), which were also modelled in other model animals 
(Reizner et al., 2014). 
4.4.2. Technique of accurate infection of zebrafish tail 
crush 
I developed a technique for accurate and effective zebrafish crush infections by direct 
injections of S. aureus to the crush site. I assessed results of several regimes of infections to 
find differences in bacteria clearance between them and to find the most efficient time 
point, which would be the most useful in biomedical research for mimicking human 
conditions. I altered volume, concentration, and timing of bacterial infection.  
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4.4.2.1. High volume of bacterial injections triggered ray loss  
In this chapter, I observed that high volume injections into the crushed ray in zebrafish tail 
resulted in the loss of rays distal to the crush. This occurred for both calcein and S. aureus 
injections, indicating that volume of injection was the critical factor. However, whilst 
calcein injected fish always regenerated these lost rays, bacterial injections reduced or 
blocked regeneration. These results indicate that infection, even if cleared from the crush 
site, have a negative effect for tail healing.  
4.4.2.2. Injection at 1dpc was optimal because of mechanical 
properties of tissues at this recovery stage 
I was able to determine that 1dpc was the most effective time point for intra-crush 
bacterial infections. Due to tissue disruption, early infection resulted in bacterial spillage 
inside and around crushed ray reducing the accuracy of injection to the crush, as well as 
bacterial retention. Bacteria injected 1dpc were able to directly reside at the crush site, 
possibly due to the partial wound closure, affording tissue stability. Soft wound closure 
seemed to form the substrate for injected pathogen.  
Injections into 2dpc crushes were much more difficult to perform. I suspect that at 2dpc 
crush site was already partially stabilized and cartilage callus was maturing, making crush 
penetration and infection troublesome. On top of that, I suspect that dense environment 
did not allow for free diffusion of injected bacterial solution, therefore bacteria were tightly 
packed in the crush site. There appeared to be fewer bacteria present in the crush after the 
infection than in the group infected 1dpc, which could explain their lowered effectiveness. 
However, since no bacteria counts were taken to compare the different injected groups, 
this statement is not backed by data.  
4.4.2.3. Injection time influence infection size  
I conclude that time of infection following the fracture is crucial for initial bacteria 
distribution, which subsequently can affect bacterial load and biofilm spreading area in the 
injury site. These results confirm clinicians’ predictions that infection time can alter 
infection strength, due to tissue accessibility (Arthur and Heber-Katz, 2011).  
4.4.3. Fish possess the ability to fight S. aureus infection 
In this chapter, I showed that adult zebrafish, similar to humans (Nauseef, 2007), and to the 
zebrafish embryos (Renshaw et al., 2006), possesses the ability to fight S. aureus infections. 
I observed that mpx marked inflammatory cells’ recruitment to the crush site was 
correlated with progressive reduction of bacterial colony numbers over time. After bone 
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injury in humans, inflammatory cells are also recruited to the infected fracture site to clear 
the bacteria residing there (Nauseef, 2007). Rodent data showed that mpx positive 
neutrophils possess anti-microbial properties and ability to communicate and recruit other 
cell types such as mesenchymal cells, osteoclasts or osteoblasts (Pape et al., 2010). 
Inflammation was shown to be a result of cumulative, simultaneous work of numerous 
anti-microbial elements, which collaborate to create an environment, optimized to kill 
microbes (Nauseef, 2007). I showed that adult zebrafish had the ability to clear S. aureus 
infection from the crush site in a similar way and simultaneously to possibly arrest 
following fracture healing stages. In addition, I reported bacterial spatial distribution 
changes, which are challenging to track in higher animals.  
4.4.4. Migration / pushing away of bacteria from the 
crush site  
In all performed crush infections, bacteria were gradually excluded from the crush site. 
Based on previous crush healing observations, as well as observations of S. aureus infected 
Tg(mpx:GFP) line, I predict that this displacement occurred due to work of the 
inflammatory cells. I observed a clearance of inflammatory cells from uninfected crushes by 
3dpc. However, in infected crushes, total clearance of neutrophils was concomitant with 
the exclusion of bacteria. Such a clearance of neutrophils was delayed in the infected 
crushes. 
4.4.5. Infection causes inflammation separate to crush 
inflammatory wave, which prolongs overall 
inflammation 
I measured the relative strength of inflammation by measuring the intensity of 
fluorescence emitted by neutrophils in Tg(mpx:GFP) line. I saw highly enhanced and 
prolonged inflammation response in the crushes infected with S. aureus. I predict that 
inflammation delay crush healing response. It is interesting to see that in infected crushes 
showing the lack of callus formation, inflammation is significantly stronger and prolonged. 
That gives reasons to believe that inflammation is inhibiting the callus deposition. It was 
shown in murine models that inflammation drives fracture recovery through cell 
recruitment and inducing cell differentiation (Pape et al., 2010). There is a full network of 
factors enabling crosstalk between inflammatory and osteogenic cells (fig 4.5) (Kansara et 
al., 2014) through which inflammatory cells might have an ability to control fracture 




Figure 4.5 Osteoclast, osteoblast and inflammatory cell crosstalk. 
Communication between bone related cells and inflammatory cells is common. Osteoclast 
differentiation requires receptor activator of nuclear factor-κB ligand (RANKL) and 
macrophage colony-stimulating factor (M-CSF). RANKL is produced by osteoblasts in 
response to prostaglandin E2 (PGE2) and 1,25 dihydroxy vitamin D3 (VitD3) and by 
activated T cells. Osteoblasts express the parathyroid hormone (PTH) receptor which can 
induce osteoclast activity by increasing RANKL expression. Immune cells produce M-CSF 
which stimulates RANK expression in monocyte–macrophage osteoclast precursor cells. 
Immune cells secrete factors which can promote or suppress osteoclast formation. 
Cytokines can be secreted by osteoclasts to facilitate T cell recruitment as well as 
activation. Macrophages produce transforming growth factor-β (TGFβ) which can induce 
osteoblast proliferation, recruit osteoblast precursors and block apoptosis. Major 
histocompatibility complex II (MHC class II) is expressed by osteoblasts in order to present 
antigen.  
GM-CSF granulocyte–macrophage colony stimulating factor; APCs antigen-presenting cells; 
HLA-DR human leukocyte antigen d-related; IFNγ interferon-γ; NK natural killer; NKT 
natural killer T; TH T-helper; OPG osteoprogerin; TNFα tumour necrosis factor-α; TReg 
regulatory T; IL interleukin 
(Kansara et al., 2014) 
 
Possible use of immune modulators to determine the role of neutrophils in this infection 
induced inhibition would be required. I performed initial experiments using hydrocortisone 
to suppress immune-response. Preliminary data showed the successful reduction in 
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inflammatory response at the crush site after hydrocortisone use. This model could be used 
in bacterial infection studies as well as the basic determination if lack of inflammation 
arrest fracture healing. It has been shown previously, that inflammatory cell ablation affect 
tail recovery after amputation (Petrie et al., 2014), therefore it would be interesting to use 
genetic ablation of inflammatory cells in the crush healing model. 
4.4.6. Bacterial presence blocks crush healing 
According to our data, healing of the crushed ray was arrested at the point at which 
bacterial infection occur and was kept on hold until bacteria were cleared away from the 
crush site and its surroundings. These results were consistent with the fracture healing 
arrest seen in infected human fractures (Arthur and Heber-Katz, 2011), indicating that 






5. Conclusions and future project 
ideas 
5.1. Crush injury is a precise animal model for human 
bone fracture studies 
I have developed and validated an in vivo bone fracture model in the zebrafish tail, showing 
that crush injury recovery followed the stages documented for human bone fracture 
healing. Stages were marked by genetic and histological markers conserved across from 
human, through mice to fish, and zebrafish crush healing appeared outwardly to mimic 
both human and murine fracture responses. I showed the usefulness of zebrafish model in 
understanding basic processes underlining human fracture healing as well as fracture 
healing under perturbed conditions, testing the crush model in animals with genetic 
disorders equivalent to human patients, showing results which follow trends seen in 
humans. I showed zebrafish crush injury as a potential model for human bone related drug 
testing and simulated bacterial infection of fractures using zebrafish. I also showed that 
zebrafish bone fracture model holds several advantages over existing fracture models in 
other research animals.  
Firstly, zebrafish offer a number of advantages as a model system, including ease of 
imaging and genome modifications allows fast generation of bone specific transgenic lines 
and mutants. The ability to recapitulate precise genetic lesions offers the ability to provide 
personalised models for genetic bone disorders of human patients in the near future. Use 
of the crush procedure developed here adds to the methods for characterising the ensuing 
bone phenotype, allowing direct evaluation of the outcome of the genetic lesion on 
fracture repair. Furthermore, the fecundity of zebrafish provides high sample numbers for 
experimental replicates, whilst compounds are easy to administer through immersion. 
The fin lepidotrichia offers an elegant and simple system for fracture analysis; both readily 
accessible for fracture, manipulation and imaging, as well as simplified with only a limited 
number of cell types in the tissue. I have demonstrated that it is possible to alter the 
fracture response through genetic, pharmacological and infection administration readily.  
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5.2. Advantages of zebrafish crush model over other 
animals 
5.2.1. Zebrafish crush model shortens experimental 
time 
The bone fracture healing process progresses faster than for any known animal model, with 
the peak of each phase reached in half of the time as compared to mice fracture model 
(Marsell and Einhorn, 2011), and thus shortens the experimental time. In sum, the system 
offers the ability to interrogate the cellular and molecular processes of fracture repair 
under normal and physiologically perturbed scenarios and will complement clinical and 
mammalian model studies. 
5.2.2. Zebrafish tail mechanical simplicity is another 
advantage of our model 
I believe that developed here zebrafish tail crush model brings an innovative view to the 
biomedical field of regenerative medicine. I developed, validated, proved and tested in the 
range of condition model, which serve as a great example for human bone fracture studies. 
The simplicity of mechanical structure of zebrafish tail work here for an advantage, serving 
with only this, what is absolutely necessary for bone fracture studies. That is exactly what 
an animal model is supposed to be. The ideal model should be a simplified and idealized 
version of complicated system, which helps in understanding it. I believe that zebrafish 
crush model is exactly what is needed to answer basic as well as more complex fracture 
healing related questions, which are too difficult to reveal from higher organisms.  
5.3. All 4 stages of healing are required for correct 
recovery  
I showed correlations between the stages and their dependency on each other and 
accumulative effects of distortion in one stage reflecting on the efficiency of others. I 
observed that presence of each stage was important and individual stages progression 
influenced the other stages.  
For example, I showed that prolonged inflammatory response led to the temporal arrest in 
healing progression. It was consistent with rodent data which showed that inflammation 
can compromise rate of healing progression by stimulating recruitment and differentiation 
of osteogenesis related cell types (Pape et al., 2010). In zebrafish, Petrie et al. (2014) 
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showed that genetic ablation of macrophages negatively influence tail formation after 
amputation. It would be of interest to determine the effect of macrophages ablation on 
fracture healing through genetic ablation or use of glucocorticoids, and to perform 
infection analysis on those fish with regards to fracture healing.  
5.4. Zebrafish respond to human drugs 
In chapter 3, I presented results which showed that zebrafish was able to respond to 
treatment with bisphosphonates, which are used heavily on the orthopaedic clinical setting 
to treat certain bone diseases. Extended exposure to very high doses of alendronate was 
deleterious to bone regrowth after fracture induction. This may have been due to the Ca++ 
chelating properties of the drug which possibly abrogated normal wound healing 
responses, although other tissue responses may be sensitive. Indeed I noted a large 
increase in spontaneous distal lepidotrichia loss and failure to regenerate. However at 
more moderate concentrations with shorter exposure durations, led to reduced callus 
remodelling, as well as a measurable reduction in spontaneous fractures in bmp1a mutant 
zebrafish. Results indicating the reduction in osteoclast activity, were consistent with 
previously published data (Yu et al., 2016).   
5.5. Fish respond to human pathogens 
I developed and validated the method of bacterial injections into the adult zebrafish tail 
crush injury. I showed the local response to the infection. Changes in standard parameters 
such as prolonged inflammation indicated that zebrafish crush is prone to infections with 
human pathogens. I believe that this technique can bring big advantages in unrevealing 
human bone infection related issues.  
5.6. Mechanism of sensing severity of injury 
Throughout the thesis, I demonstrated that a standardised zebrafish fracture is sensitive to 
external factors like drugs, genetic mutations, mechanical crush distortions and infection. 
Based strength of the influencing factor, crush healing reacted differently. Healing either 
performed normally; was temporarily arrested, was completely blocked, or redirected from 
crush healing to epimorphic regeneration by losing distal part of broken ray and 
introducing mini blastema formation.  
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Based on those observations I propose that there is an inflammatory cells driven, injury 
severity sensing mechanism, allowing zebrafish to undertake actions adequate to the 
situation. I believe that this mechanism is highly regulated on a molecular level via cellular 
cross-talk mentioned above. Unrevealing details of this mechanism would be the aim of my 
future work.   
5.7. Zebrafish tail crush injury model open doors to 
answers of many not resolved queries connected to 
human fracture healing  
I believe that the zebrafish crush model possesses the potential to help scientists in many 
diverse fields within the biomedical research of human fracture healing. Genetic 
predisposition, drug treatment and bacterial infections of the crush were presented in 
here, however, I believe that possibilities of this model usage are endless. The Zebrafish 
crush model has certain limitations, such as bone structure or aquatic life style, however I 
believe that they could be outweighed by possible advantages, which the use of the model 
can bring. I think that the crush method is simple in execution, therefore easy to 
reproduce, which certainly helps in comparing results between studies. I trust that this 
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